WO2003053419A1 - Coated tablets and process for producing the same - Google Patents

Coated tablets and process for producing the same Download PDF

Info

Publication number
WO2003053419A1
WO2003053419A1 PCT/JP2002/013297 JP0213297W WO03053419A1 WO 2003053419 A1 WO2003053419 A1 WO 2003053419A1 JP 0213297 W JP0213297 W JP 0213297W WO 03053419 A1 WO03053419 A1 WO 03053419A1
Authority
WO
WIPO (PCT)
Prior art keywords
tablet
coating
polymer
tablets
uncoated
Prior art date
Application number
PCT/JP2002/013297
Other languages
French (fr)
Japanese (ja)
Inventor
Takahiro Yamamura
Kenta Wada
Takeshi Nakamura
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Priority to AU2002357611A priority Critical patent/AU2002357611A1/en
Priority to KR10-2004-7009561A priority patent/KR20040073492A/en
Priority to JP2003554178A priority patent/JP4398253B2/en
Publication of WO2003053419A1 publication Critical patent/WO2003053419A1/en
Priority to HK05104710A priority patent/HK1071524A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Definitions

  • the present invention relates to a method for producing a coated tablet containing a hygroscopic polymer as a main component, and more particularly to a method for producing a film-coated tablet.
  • the present invention also relates to a coated tablet obtained by the production method.
  • a film coating method, a sugar coating method and the like have been known as a coating method for tablets containing a hygroscopic polymer as a main component.
  • a film coating method for example, a method of coating an uncoated tablet obtained by impregnating an anion exchange resin with a certain amount of water and compressing it with a coating liquid containing hydroxypropylcellulose or the like is known.
  • Japanese Unexamined Patent Publication No. Hei 6-157735 Japanese Unexamined Patent Publication No. Hei 6-157735
  • a method is also known in which uncoated tablets obtained by adding 14 to 20% by weight of water and 2% by weight or less of silicon dioxide to an anion exchange resin are coated with hydroxypropylmethylcellulose ( Japanese Patent Laid-Open No. 7-97330).
  • these methods have a problem that the strength of the tablet is reduced because the uncoated tablet needs to contain a certain amount of water.
  • WO 0220208 which states that film coating may be applied to form a film tablet.
  • a commercially available coating machine is actually used.
  • a film tablet was manufactured using the same.
  • the surface strength of the tablet decreases because the film-forming agent solution spreads while wetting the entire surface of the tablet.
  • the surface of the tablet was roughened in the early stage of coating, and the aesthetic appearance was impaired, and the thickness of the film was not uniform, so that the desired film function could not be obtained.
  • An object of the present invention is to provide a method for producing a coated tablet containing a hygroscopic polymer as a main component, and particularly a method for producing a film-coated tablet, which is excellent in tablet surface smoothness and is uniformly coated. Another object is to provide a coated tablet having excellent tablet surface smoothness.
  • the present inventors have conducted intensive studies and as a result, obtained a plain tablet containing 50% or more of a hygroscopic polymer under the condition that the thermal expansion ability of the plain tablet is not completely lost (ie, Pre-heating under the condition that the thermal expansion capacity of the uncoated tablet remains at least partially), and then, during or after the application of the coating liquid, the heated tablet is thermally expanded to generate the initial stage of coating.
  • the present inventors have found that the roughened surface of the prepared tablet is restored, and completed the present invention.
  • FIG. 1 is an example of a graph showing the time transition at various temperatures of the thickness increase of the uncoated tablet obtained in Example 1.
  • FIG. 2 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 5.5% by weight) obtained in Example 1 due to heating.
  • FIG. 3 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 3.0% by weight) obtained in Example 2 due to heating.
  • FIG. 4 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 3.8% by weight) obtained in Example 2 due to heating.
  • FIG. 5 is an example of a graph showing the time transition of the increase in thickness of the uncoated tablet (water content: 8.0% by weight) obtained in Example 3 due to heating.
  • FIG. 6 is an example of a top photograph showing the appearance of the coated tablet produced in Example 4.
  • FIG. 7 is an example of a side photograph showing the appearance of the coated tablet manufactured in Example 4.
  • FIG. 8 is an example of a top photograph showing the appearance of the coating tablet produced in Example 5.
  • FIG. 9 is an example of a top photograph showing the appearance of the coated tablet produced in Comparative Example 1.
  • FIG. 10 is an example of a side photograph showing the appearance of the coated tablet produced in Comparative Example 1.
  • the present invention is directed to uncoated tablets containing 50% by weight or more of a hygroscopic polymer.
  • Such uncoated tablets have a thermal expansion capability, but if heated sufficiently, the original thermal expansion capability is completely lost. That is, the present invention pre-heats such uncoated tablets under the condition that the thermal expansion ability is not completely lost (that is, the condition that at least a part of the thermal expansion ability is left), and then the coating liquid is heated.
  • a coated tablet containing a hygroscopic polymer as a main component wherein the surface condition of the tablet is restored by maintaining the tablet under sufficient conditions during or after the application. And a method for producing the same.
  • the present invention also relates to a coated tablet obtained by the above production method.
  • the coating means a known coating method applicable to coating of ordinary tablets, such as film coating and sugar coating, and among them, film coating is preferable. That is, the coated tablet is preferably a film-coated tablet.
  • the term "absorbent polymer” refers to a high-absorbent polymer having a water content of 10% by weight or more within one week under a room temperature (22 to 28 ⁇ ) at a relative humidity of 50%. Means molecule.
  • Acrylic acid polymer (acrylic acid-vinyl alcohol polymer) Methacrylic acid polymer
  • Arylamine-based polymer Carboxymethyl cellulose polymer
  • the above-mentioned polymers also include these copolymers, and copolymers of these monomers with other monomers copolymerizable with them and graft-polymerizable polymers.
  • Such a copolymer may be a random polymer, a block polymer, or a graft polymer.
  • a crosslinked product of each polymer prepared according to a conventional method using various crosslinking agents is also included.
  • cross-linking agent various kinds of polyaryls, polyhydric pinyls, polyhydric epoxies, halo epoxies, polyhydric alcohols, polyhydric amines, hydroxyvinyls and the like can be used. .
  • copolymerizable monomers include, for example, alkyl (e.g., hydroxyethyl (meth) acrylate, (methoxy) polyethylene glycol (meth) acrylate, dariserine (meth) acrylate, and glycosylethyl (meth) acrylate.
  • alkyl e.g., hydroxyethyl (meth) acrylate, (methoxy) polyethylene glycol (meth) acrylate, dariserine (meth) acrylate, and glycosylethyl (meth) acrylate.
  • (Meth) acrylates acrylamide compounds such as N, N-dimethylacrylamide and acrylamide; carboxylic acid compounds such as maleic acid and its metal salts, itaconic acid and its metal salts; 2-acrylamide Examples thereof include sulfonic acid compounds such as 2-methylpropanesulfonic acid and its metal salt, vinylsulfonic acid and its metal salt, styrenesulfonic acid and its metal salt; and N-vinylpyrrolidone.
  • polymer that can be graft-polymerized with (meth) acrylic acid examples include starch, carrageenan, agarose, and hydrophilic polysaccharides such as carboxymethyl cellulose.
  • N, N-diarylacrylamide and N, N-diarylmethylacrylamide (these are referred to as “N, N-diaryl (meth) acrylamide”, the same applies hereinafter), diarylamine, Polyvalent aryl compounds such as diaryl methacrylamine, diaryl phthalate, and diaryl malate;
  • Polyvinyls divinylbenzene, N, N "-methylenebis (meth) acryl Amide, ethylene glycol di (meth) acrylate and polyethylene glycol di (meth) acrylate (these are referred to as “(poly) ethylene glycol di (meth) acrylate”, the same applies hereinafter), and (poly) propylene glycol (Meta) Polyvalent vinyl compounds such as acrylate and trimetalol propane triacrylate.
  • Polyepoxys (poly) ethylene glycol diglycidyl ether, (poly) propylene glycol diglycidyl ether, glycerin-1,3-diglycidyl ether, trimethylolpropane triglycidyl ether, (poly) glycerin polyglycidyl ether, etc. Polyepoxy compound.
  • Haloepoxys epichlorohydrin, ⁇ -methylchlorohydrin and the like.
  • Polyhydric alcohols (poly) glycerin, (poly) ethylene glycol, trimethylolpropane, pentaerythritol and the like.
  • Polyvalent amines ethylenediamine and the like.
  • the hygroscopic polymer used in the present invention is preferably a polyallylamine-based water-absorbing polymer, and more preferably a water-absorbing polymer obtained by crosslinking and polymerizing polyallylamine with epichlorohydrin.
  • the water-absorbing polymer represented by the formula (1) can be prepared, for example, by the method described in Japanese Patent Publication No. 9-504782 (International Publication WO 95Z05184) or the international publication WO 00/22008. Can be obtained according to the method described in, for example.
  • the following polymers (2) to (9) can also be suitably used.
  • the polymer (2) has the following formula
  • n is an integer
  • R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as an ethylamino group).
  • An alkylamino group containing 5 carbon atoms) or an aryl group eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)).
  • the polymer (3) has the following formula
  • n is an integer
  • R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as an ethylamino group). Alkylamino group containing 5 carbon atoms), or aryl (Eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)), and X is an exchangeable negatively charged counterion.
  • copolymer of the above polymer (3) examples include the following formula:
  • n is an integer
  • R is independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 5 such as an ethylamino group).
  • An alkylamino group containing 1 to 12 carbon atoms) or an aryl group eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)
  • Is a charged counterion and the following formula
  • n is each independently an integer
  • R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, an ethylamino group).
  • Polymer (4) characterized by having a second repeating unit.
  • the polymer (5) has the following formula Or a copolymer thereof having a repeating unit represented by the following formula: Wherein n is an integer, R is H or a lower alkyl group (eg, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (eg, containing 1 to 5 carbon atoms such as an ethylamino group) An alkylamino group) or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (eg, a phenyl group, a naphthyl group, etc.)).
  • R is H or a lower alkyl group (eg, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (eg, containing 1 to 5 carbon atoms such as an ethylamino group) An alkylamino group) or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (e
  • R is H or a lower alkyl group (eg, an alkyl group containing 1-5 carbon atoms), an alkylamino group (eg, 1-5 carbon atoms such as an ethylamino group)
  • an alkyl group containing 1 to 12 carbon atoms for example, an aryl group containing 1 to 12 carbon atoms (for example, a phenyl group, a naphthyl group, etc.)
  • a first repeating unit represented by the following formula:
  • n is independently an integer;
  • R is H or a lower alkyl group (eg, an alkyl group containing 1 to 5 carbon atoms); an alkylamino group (eg, 1 to 5 such as an ethylamino group); An alkylamino group containing a carbon atom) or an aryl group (For example, an aryl group containing 1 to 12 carbon atoms (for example, phenyl group, naphthyl group, etc.)). 6))).
  • the polymer (7) has the following formula
  • n is an integer
  • R and R 2 are each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as ethylamino group).
  • X is each interchangeable This is a negatively charged pair.
  • preferred polymers are also one and less of R ## or R 2 in the formula is a hydrogen, a polymer.
  • the polymer (8) has the following formula
  • n is an integer
  • 1 ⁇ and R 2 are each independently H or an alkyl group containing 1 to 20 carbon atoms, an alkylamino group (for example, 1 to 5 carbon atoms such as ethylamino group).
  • Alkyl groups containing 1 to 12 atoms eg, aryl groups containing 1 to 12 carbon atoms
  • phenyl Group, naphthyl group, etc. e.g, phenyl Group, naphthyl group, etc.
  • the polymer (9) has the following formula
  • R and R 2 and R 3 are each independently H or an alkyl group containing 1 to 20 carbon atoms, an alkylamino group (for example, an alkylamino group containing 1 to 5 carbon atoms such as an ethylamino group), Or an aryl group containing from 1 to 12 atoms (eg, an aryl group containing from 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)), where X is each exchangeable negatively charged It is a counter ion.
  • the negatively charged counterion may be an organic ion, an inorganic ion, or a combination thereof.
  • Inorganic ions suitable for use in the present invention include halides (especially chlorides), phosphates, phosphites, carbonates, carbonates, sulfates, hydrogensulfates, hydroxides, nitrates, These are persulfate, sulfite and sulfide ions.
  • Preferred organic ions include acetate, ascorbate, benzoate, citrate, dihydrogenate, monohydrogenate, oxalate, succinate, tartrate, taurocholate Salt, glycocholate, and cholate ions.
  • a super-absorbent polymer is a substance that absorbs more than 10 mL of water by lg, changes into a gel without fluidity, and absorbs water even if a slight pressure is applied. Means a polymer that exhibits a strong water retention capacity that does not escape.
  • the water-absorbing polymer include the polymers exemplified as the hygroscopic polymer.
  • An uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention can be produced by a conventional method such as a direct powder compression method or an indirect powder compression method. In tableting, a suitable excipient, disintegrant, fluidizing agent, Additives such as a mixture, a lubricant, a coloring agent, and a fragrance may be contained within a range not to impair the object of the present invention.
  • the amount of the fluidizing agent contained is preferably 1% by weight or less based on the total weight of the uncoated tablet.
  • the amount of the binder contained is preferably not more than 20% by weight based on the total weight of the uncoated tablet.
  • the amount of the lubricant contained is preferably 0.05 to 1% by weight based on the total weight of the uncoated tablet.
  • excipient examples include cellulose or cellulose derivatives such as crystalline cellulose and low-substituted hydroxypropyl cellulose; starch or starch derivatives such as corn starch and dextrin; sugars such as lactose, sucrose, and D-mannitol; Sugar alcohols; inorganic excipients such as dried aluminum hydroxide gel, precipitated calcium carbonate, synthetic aluminum silicate, magnesium aluminate metasilicate, light anhydrous silicic acid, hydrogen phosphate and the like.
  • cellulose or cellulose derivatives such as crystalline cellulose and low-substituted hydroxypropyl cellulose
  • starch or starch derivatives such as corn starch and dextrin
  • sugars such as lactose, sucrose, and D-mannitol
  • Sugar alcohols inorganic excipients such as dried aluminum hydroxide gel, precipitated calcium carbonate, synthetic aluminum silicate, magnesium aluminate metasilicate, light anhydrous silicic acid, hydrogen
  • binder examples include cellulose or cellulose derivatives such as hydroxypropylcellulose, low-substituted hydroxypropylcellulose, methylcellulose, hydroxypropylmethylcellulose, and carboxymethylethylcellulose; starch such as corn starch; Starch derivatives such as hydroxypropyl starch; pullulan, polyvinyl alcohol, polyvinylpyrrolidone, acacia, gelatin, tragacanth, and the like.
  • starch such as corn starch
  • Starch derivatives such as hydroxypropyl starch
  • pullulan polyvinyl alcohol, polyvinylpyrrolidone, acacia, gelatin, tragacanth, and the like.
  • disintegrating agent examples include carmellose or a cellulose derivative such as sodium salt or calcium salt thereof and croscarmellose sodium; starch or a starch derivative such as wheat starch and carboxymethyl starch sodium; sodium alginate; Can be.
  • the fluidization aid examples include hydrogenated oil, polyoxyethylene hydrogenated castor oil, polyoxyl stearate, polyoxyethylene polyoxypropylene glycol, polysorbate, and fatty acid esters of anhydrous sorbitol such as sorbitan sesquioleate; Glycerin monostearate, lauromacrogol and the like can be mentioned.
  • Lubricants include, for example, stearic acid, magnesium stearate, stearic Higher fatty acids such as calcium phosphate and metal salts thereof; talc, sodium lauryl sulfate, sucrose fatty acid ester, colloid silica and the like.
  • the uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention can be produced by mixing each component and tableting.
  • the tablet manufacturing method used in the present invention is not particularly limited, and known methods such as a direct powder compression method, a semi-direct powder compression method, a dry granulation compression method, and a wet granulation compression method can be suitably used.
  • An uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention should have a water content of 10% by weight or less for preheating under the condition that the thermal expansion ability is not completely lost. It is good.
  • the uncoated tablet containing 50% or more of the hygroscopic polymer of the present invention is specifically described in, for example, Japanese Patent Application Laid-Open No. H10-33069 (International Publication WO98444993). Publication), the method described in International Publication WO 00Z2208, and the like.
  • the coating agent used for coating in the present invention is not particularly limited, and a coating agent usually used for coating tablets can be used.
  • a film coating agent can be obtained by dissolving a film base using purified water as a solvent, dispersing a lubricant, a light-blocking agent, a dye, and the like, and mixing the solid content with water. .
  • the coating agent used in the present invention may contain various additives such as a plasticizer, a lubricant, a light shielding agent, and a pigment as a solid content.
  • concentration of the solid content is usually 1 to 20% by weight.
  • film base used in the above-mentioned coating agent those generally added can be used.
  • a gastric film coating base or an enteric or sustained release film coating can be used.
  • the base and the like can be appropriately selected.
  • gastrosoluble film coating base examples include cellulose derivatives such as hydroxypropylcellulose and hydroxypropylmethylcellulose; polyvinylacetate ylethylethyl acetate, aminoalkyl methacrylate copolymer E [Eudragit E (trade name) , ROHM FALMA, Inc. Synthetic polymers such as pyrrolidone; dextrin, pullulan, zein, sodium alginate, gelatin, sucrose and the like.
  • enteric or sustained release film coating base examples include cellulose derivatives such as ethylcellulose, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, carboxymethylethylcellulose, and cellulose acetate fluorate.
  • Acrylic such as methacrylic acid copolymer L or LD (Eudragit L-30D55, (trade name), Rohm Pharma Co.), aminoalkyl acrylate copolymer RS (Eudragit RS (trade name), Rohm Pharma Co.) Acid-based polymers; natural products such as shellac;
  • the use amount of the film base does not need to be a special value, and may be 50% by weight or more based on the film layer.
  • plasticizer used in the coating agent examples include macrogol (polyethylene glycol), triethyl citrate, triacetin, medium-chain fatty acid triglyceride, and glycerin.
  • the amount of the plasticizer added is usually less than 50% by weight based on the total solids in the coating solution.
  • lubricant used in the above coating agent examples include talc, stearic acid, magnesium stearate, and sucrose fatty acid ester.
  • the amount of lubricant added is usually less than 50% by weight, based on the total solids in the coating liquid.
  • Examples of the light-shielding agent or pigment used in the coating agent include metal oxides such as titanium oxide, yellow sesquioxide, red sesquioxide, and black sesquioxide, and evening dyes.
  • the addition amount of the light-shielding agent or the dye is usually less than 50% by weight based on the total solid content in the coating solution.
  • the method of applying the coating liquid used in the present invention is not particularly limited, and a known method can be suitably used. However, it is preferable to coat the uncoated tablet by spraying using a commercially available coating apparatus. There is no particular limitation on the amount of coating liquid applied. However, it is preferable that the amount of the coating be 1 to 10% by weight based on the uncoated tablet. In addition, after the uncoated tablet is coated with the above film amount and the surface of the tablet is repaired at the initial stage of coating, if sufficient strength (film strength for film coating agent) is obtained, The same or different coating liquids can be applied by conventional methods.
  • the coating in the production method of the present invention is performed under the condition that the thermal expansion capacity of the uncoated tablet containing 50% or more of the hygroscopic polymer is not completely lost (that is, at least a part of the thermal expansion capacity is left). Under such conditions), and then, while or after applying the coating solution, maintaining the tablet under conditions such that the tablet is sufficiently expanded.
  • the thermal expansion means deformation accompanied by an increase in the thickness of the tablet caused by heating.
  • the conditions under which the thermal expansion capacity of the uncoated tablet is not completely lost, and the conditions under which the tablet is sufficiently expanded thereafter, are determined by measuring the increase in the thickness of the uncoated tablet (heating tablet) due to heating. be able to.
  • the amount of increase in the thickness of the tablet due to heating can be determined by maintaining the tablet at a specified temperature (for example, at 30, 40, 50, 60 ° C, 70, 80, etc.) for a predetermined period of time. It can be obtained by measuring the thickness of the tablet every time (for example, every 5 minutes, every 10 minutes, etc.) and comparing it with the thickness of the tablet before heating.
  • the conditions under which the tablet is sufficiently expanded are conditions under which the increase in the thickness of the tablet measured as described above is close to the maximum, and when the coating liquid is applied or after the coating liquid is applied, or when the coating liquid is applied. Appropriate temperatures must be set for both.
  • the condition is such that the amount of increase in thickness when the tablet is held for a certain time under the condition is 0.5% or more of the thickness of the uncoated tablet, preferably 2.5% or more. More preferably, the condition is 5.0% or more.
  • the tablet temperature under such conditions that the tablet is sufficiently expanded is usually a temperature at which the amount of increase in thickness when the tablet is held at that temperature for 20 minutes is 0.5% or more of the thickness of the uncoated tablet, and is preferable. Is a temperature at which the above-mentioned increase in thickness becomes 2.5% or more of the thickness of the uncoated tablet, and more preferably a temperature at which the above-mentioned thickness increase becomes 5.0% or more of the thickness of the uncoated tablet.
  • the tablet temperature under conditions that cause the tablet to swell sufficiently is coating It is preferable that the tablet temperature is maintained at 40 ° C. or higher when the liquid is applied, and the tablet temperature is maintained at 50 or higher after the coating liquid is applied.
  • the tablet temperature under conditions that sufficiently swell the tablet is as follows: when the coating liquid is applied, the tablet temperature is 40: to 70: After the coating liquid is applied, the tablet temperature is preferably maintained at 55 to 85.
  • the time required to maintain the tablet under sufficient conditions to swell the tablet is the time required for the smoothness of the tablet surface to reach the desired state, and is usually 30 minutes or more, and preferably 60 minutes or more. More preferably, it is 90 minutes or more.
  • sufficient strength film strength in the case of a film coating agent
  • the same or different coating liquid can be applied in a conventional manner. For purposes other than surface smoothness improvement, improvement of stability of the active substance, improvement of usability, control of release time of the active substance, etc.) can be performed for a time longer than sufficient.
  • conditions for sufficiently swelling the tablet while applying the coating liquid are usually at a tablet temperature of 40 to 60 ° C for 60 minutes to 40 ° C. 0 minutes, and preferably 120 to 400 minutes at a tablet temperature of 40 to 60 ⁇ .
  • the conditions under which the tablet is coated with a coating liquid and then sufficiently swelled are usually at a tablet temperature of 55 to 85 at a temperature of 10 to 10 minutes.
  • the tablet temperature is preferably at least 30 minutes at a tablet temperature of 55 to 85 t :, and more preferably at least 30 minutes at a tablet temperature of 60 to 80.
  • Preheating the uncoated tablet under the condition that its thermal expansion capacity is not completely lost means that the tablet (uncoated tablet) after preheating is kept under such conditions that the thickness increase of the uncoated tablet causes the tablet to expand sufficiently.
  • Means preheating under the condition that the thickness increase of the tablet at the time is 3 Z 5 or less, and when the thickness increase of the tablet after preheating is maintained under conditions that allow the tablet to expand sufficiently
  • Preheating is preferably performed under conditions that are 2/5 or less of the thickness increase of the tablet, and when the thickness increase of the tablet after preheating is maintained under conditions that allow the tablet to expand sufficiently. 1 to 5 or less of the thickness increase of tablets It is preferable to preheat under the conditions.
  • the hygroscopic polymer is a polyallylamine-based water-absorbing polymer
  • the tablet temperature should be reduced to ⁇ 60 ⁇ at a tablet temperature of 40. It is preferred to preheat until reaching.
  • the time required for preheating the uncoated tablet under the condition that its thermal expansion capacity is not completely lost is usually about 5 to 60 minutes, and is preferable. Is 5 to 20 minutes.
  • the preheating in this case is preferably performed at a supply air temperature of 50 to 70.
  • the water content of the uncoated tablet must be within the range where the shape and hardness of the tablet do not significantly change, and the thickness increase of the tablet is limited. It is preferable that the amount varies depending on the holding temperature.For example, the thickness increase when the tablet is held at 50 for 10 minutes is 1 Z 2 of the thickness increase when the tablet is held at 80 and 10 minutes. The following is preferred.
  • the water content of the uncoated tablet is preferably from 3% by weight to 10% by weight based on a drying loss method for 105 hours. It is more preferable that the content be 3% by weight or more and 8% by weight or less.
  • the method of adjusting the water content of the uncoated tablet is to mix the raw material hygroscopic polymer and various additives in a state where the water content is adjusted in advance to the desired water content, and then press the tablet. It is. Other methods include manufacturing uncoated tablets and storing them in a conditioned environment, or drying them using a commonly used drying method such as a vacuum drying method. Care must be taken to avoid this.
  • the water content of the tablet can be measured by, for example, a loss on drying method, and the measurement condition is preferably 105 to 3 hours.
  • the above-mentioned tablet temperature can be measured using various commercially available devices, for example, using a non-contact thermometer or the like.
  • the measurement error with a non-contact thermometer is generally about ⁇ 1% (or ⁇ 2) of the reading.
  • the present invention will be described in more detail by the following examples and test examples.
  • the tablet temperature is The measurement was performed using a portable non-contact thermometer PT-3 LF (made by Optex Corporation).
  • Polyallylamine epichlorohydrin cross-linked polymer (generic name: sevelamer hydrochloride (r-INN), water content 5.5% by weight) 86.2 1% by weight, crystalline cellulose 1 3.62% by weight, Lubriwax 101 0.12% by weight was put into a mold mixer, mixed at 15 rpm for 15 minutes, then 0.05% by weight of magnesium stearate was added thereto, and further mixed at 15 rpm for 1 minute. .
  • This mixed powder was tableted with a single-tally tableting machine (X-45 manufactured by Hattetsu Corporation) to produce uncoated tablets (water content: 5.5% by weight, hardness: 10 kgf). The water content was measured by the loss on drying method (105, 3 hours).
  • Example 2 The uncoated tablet obtained in Example 1 was dried overnight in a desiccator containing silica gel to prepare an uncoated tablet having a water content of 3.0% by weight and an uncoated tablet having a water content of 3.8% by weight.
  • the water content was measured by the drying loss method (105 ° C, 3 hours).
  • the uncoated tablet obtained in Example 1 was absorbed in a room to prepare an uncoated tablet having a water content of 8.0% by weight.
  • the water content was measured by the loss on drying method (105 hours, 3 hours).
  • Example 1 The uncoated tablets obtained in Example 1 were placed in a constant temperature bath at 40, 501 :, 60 ° C. and 70, sampling was performed every 5 minutes up to 60 minutes, and the thickness of the tablets was measured with a thickness gauge.
  • Fig. 1 shows an example of the results showing the time course of the tablet thickness increase (difference from before heating) at each temperature.
  • Example 1 The uncoated tablet obtained in Example 1 (water content 5.5% by weight), the uncoated tablet obtained in Example 2 (water content 3.0% by weight and water content 3.8% by weight) and The uncoated tablets (water content 8.0% by weight) obtained in Example 3 were placed in an 80 "constant temperature bath at 60 and 70, respectively, and sampled every 10 minutes until 30 minutes.
  • Example of the results showing the time change of the tablet thickness increase at each temperature Are shown in FIGS. 2 to 5, respectively.
  • hydroxypropyl methylcellulose 600% by weight of macrogol, 2% by weight of titanium oxide and 0.5% by weight of talc were dissolved or dispersed in 90% by weight of purified water to prepare a coating solution.
  • Example 2 5.0 kg of the uncoated tablets prepared in Example 1 were put into a coating machine (PAREX, 0 (: -500 type)) and preliminarily dried for 10 minutes at a set air supply temperature of 55.
  • the tablet temperature was 51.
  • the spray amount of the spray liquid was sprayed at 6 mgZ minutes until 60 minutes later, and then sprayed at 12 mgZ minutes, and 2 1 Spraying was performed for 0 minutes, and the tablet temperature during this period was 45 to 49.
  • the air supply set temperature was set to 70, and post-drying was performed for 180 minutes.
  • Example 1 The test was carried out using the uncoated tablet produced in Example 1 and the coating solution prepared in Example 4. 195.8 kg of the uncoated tablet prepared in Example 1 was put into a coating machine (HCF-150, manufactured by Freund Corporation). Preliminary drying was performed at a set air supply temperature of 70 for 9 minutes. The tablet temperature at the end of predrying was 52. Next, at the set air supply temperature of 58 to 80, the spraying amount of the spray liquid was 24 OmLZ minutes until 60 minutes later, 30 OmL / minute until 120 minutes later, and 36 OmLZ minutes thereafter. Sprayed and sprayed for 222 minutes. The tablet temperature during this period was 48-54. After the end of spraying, the air supply set temperature was set to 70, and post-drying was performed for 360 minutes. The tablet temperature at the end of post-drying was 75.
  • Example 4 The test was performed using the same uncoated tablet as in Example 1 and the coating liquid prepared in Example 4. 200,4 kg of uncoated tablets prepared according to Example 1 were charged into a coating machine (AQC-150F, manufactured by Freund Corporation). It was pre-dried for 18 minutes at a set air supply temperature of 50-75. The tablet temperature at the end of the preliminary drying was 42 t :. Next, at the set air supply temperature of 57 to 75, the spray amount of the spray liquid was 32 OmLZ minutes until 60 minutes later, and 40 OmL / minute until 120 minutes thereafter. Spray at 48 OmL / min. Sprayed for 80 minutes. The tablet temperature during this time was 42-48. After the spraying, the set air supply temperature was set at 70, and post-drying was performed for 120 minutes. The tablet temperature at the end of post-drying was 68.
  • AQC-150F manufactured by Freund Corporation
  • Example 4 The test was carried out using the uncoated tablet produced in Example 1 and the coating solution prepared in Example 4.
  • 5.0 kg of the uncoated tablet prepared in Example 1 was charged into a coating machine (PARC, DRC-500 type).
  • Preliminary drying was performed at an air supply set temperature of 70 for 105 minutes.
  • the tablet temperature at the end of predrying was 72.
  • spray the spray liquid at 6 mg Z minutes until 30 minutes later, spray at 12 mg Z minutes thereafter, and spray for 170 minutes. went.
  • the tablet temperature during this period was 44-65.
  • the air supply set temperature was set at 70 and post-drying was performed for 60 minutes.
  • the tablet temperature after the post-drying was 68.
  • Ra arithmetic mean roughness
  • the production method of the present invention solves the problems of the prior art, has excellent tablet surface smoothness that could not be provided conventionally, has a uniform coating, and has a hygroscopic property. Providing coated tablets based on polymers It is possible.
  • the uncoated tablet containing 50% or more of the hygroscopic polymer is preliminarily subjected to the condition that the thermal expansion ability is not completely lost (that is, the condition that at least a part of the uncoated tablet has the thermal expansion ability).
  • a new and unique manufacturing method that repairs the rough surface of the tablet that occurred at the beginning of coating by heating and then thermally expanding the heated tablet with or after applying the coating liquid. It is a very useful and useful tool that opens a new perspective in tablet manufacturing.

Abstract

It is intended to provide coated tablets having a high surface smoothness produced by pre-heating uncoated tablets comprising a hygroscopic polymer as the main component under such conditions as not completely damaging the thermal expansibility, and allowing further thermal expansion by heating the tablets while applying a coating solution or after applying the same to thereby smoothen the tablet surface having become rough in the early stage of the coating. In the case of forming coated tablets by coating uncoated tablets comprising a hygroscopic polymer, a coating solution is spread while moistening over the entire surface of the uncoated tablets and thus the surface strength of the tablets is lowered. As a result, the surface of the uncoated tablets becomes rough in the early stage of the coating and thus the appearance of the coated tablets is worsened, or the coating film thickness becomes uneven. These problems can be overcome by the above method.

Description

明 細 書 コーティング錠剤及びその製造方法 [技術分野]  Description Coated tablets and production method thereof [Technical field]
本発明は、 吸湿性高分子を主成分とするコーティング錠剤の製造方法に関し、 特にフィルムコーティング錠剤の製造方法に関する。 また、 該製造方法により得 られるコーティング錠剤にも関する。  The present invention relates to a method for producing a coated tablet containing a hygroscopic polymer as a main component, and more particularly to a method for producing a film-coated tablet. The present invention also relates to a coated tablet obtained by the production method.
[背景技術] [Background technology]
従来、 吸湿性高分子を主成分とする錠剤のコーティング方法としては、 フィル ムコーティング方法、 糖衣コーティング方法等が知られている。 この中でもフィ ルムコーティング方法としては、 例えば、 陰イオン交換樹脂に一定量の水分を含 有させて打錠した素錠を、 ヒ ドロキシプロピルセルロース等を含むコーティング 液によりコーティングする方法が知られている(特開平 6— 1 5 7 3 2 5号公報)。 また、 陰イオン交換樹脂に対し 1 4〜2 0重量%の水および 2重量%以下の二酸 化ケィ素を添加した素錠をヒ ドロキシプロピルメチルセルロースによりコーティ ングする方法が知られている (特開平 7— 9 7 3 3 0号公報) 。 しかしながら、 これらの方法では、 素錠に一定量の水分を含有させる必要があるため、 錠剤の強 度が低下するという問題があった。  Conventionally, a film coating method, a sugar coating method and the like have been known as a coating method for tablets containing a hygroscopic polymer as a main component. Among these, as a film coating method, for example, a method of coating an uncoated tablet obtained by impregnating an anion exchange resin with a certain amount of water and compressing it with a coating liquid containing hydroxypropylcellulose or the like is known. (Japanese Unexamined Patent Publication No. Hei 6-157735). A method is also known in which uncoated tablets obtained by adding 14 to 20% by weight of water and 2% by weight or less of silicon dioxide to an anion exchange resin are coated with hydroxypropylmethylcellulose ( Japanese Patent Laid-Open No. 7-97330). However, these methods have a problem that the strength of the tablet is reduced because the uncoated tablet needs to contain a certain amount of water.
また、 陰イオン交換樹脂に、 水分を加えることなく、 二酸化ケイ素および結晶 セルロースを添加した混合物を打錠した素錠を、 ヒ ドロキシプロピルメチルセル ロース等を含むコーティング液によりスプレーコーティングする方法も知られて いる (特開平 9— 2 0 2 7 3 2号公報、 特開平 1 0— 1 1 4 6 6 1号公報) 。 ま た、 吸湿性高分子 (ポリアリルアミン系高分子) を含有する錠剤については、 特 開平 1 0— 3 3 0 2 6 9号公報 (国際公開 WO 9 8 / 4 4 9 3 3号公報) や国 際公開 WO 0 0 2 2 0 0 8号公報に示されており、 この両者ではフィルムコ 一ティングを施してフィルム錠としてもよいとの記載があり、 特に後者では実際 に市販のコーティング機を用いてフィルム錠を製造したという実施例も記載され ている。 しかしながら、 上記の方法でポリアリルアミン系高分子などの吸湿性高分子の 錠剤をコーティングした場合には、 フィルム形成剤溶液が錠剤の表面全体をぬら しながら広がることによって錠剤の表面強度が低下するため、 コ一ティング初期 に錠剤表面に荒れが生じ、 美観を損なったり、 膜の厚みが均一でなくなるために 目的とするフィルム機能が得られない等の問題があつた。 Also, a method is known in which an unexchanged tablet obtained by tableting a mixture obtained by adding silicon dioxide and crystalline cellulose to an anion exchange resin without adding water is spray-coated with a coating solution containing hydroxypropylmethylcellulose or the like. (Japanese Unexamined Patent Application Publication No. 9-220732, Japanese Unexamined Patent Application Publication No. 10-114661). Tablets containing a hygroscopic polymer (polyallylamine-based polymer) are disclosed in Japanese Patent Application Laid-Open No. 10-33069 (International Publication WO98 / 444933) and It is disclosed in International Publication No. WO 0220208, which states that film coating may be applied to form a film tablet.In the latter case, a commercially available coating machine is actually used. There is also described an example in which a film tablet was manufactured using the same. However, when a tablet of a hygroscopic polymer such as a polyallylamine-based polymer is coated by the above method, the surface strength of the tablet decreases because the film-forming agent solution spreads while wetting the entire surface of the tablet. However, the surface of the tablet was roughened in the early stage of coating, and the aesthetic appearance was impaired, and the thickness of the film was not uniform, so that the desired film function could not be obtained.
本発明は、 錠剤表面の平滑度が優れ、 均一にコーティングされた、 吸湿性高分 子を主成分とするコーティング錠剤の製造方法、 特にフィルムコーティング錠剤 の製造方法を提供することを目的とする。 また、 錠剤表面の平滑度が優れたコー ティング錠剤を提供することをも目的とする。  An object of the present invention is to provide a method for producing a coated tablet containing a hygroscopic polymer as a main component, and particularly a method for producing a film-coated tablet, which is excellent in tablet surface smoothness and is uniformly coated. Another object is to provide a coated tablet having excellent tablet surface smoothness.
[発明の開示]  [Disclosure of the Invention]
本発明者らは、上記課題に鑑み、鋭意研究を重ねた結果、吸湿性高分子を 5 0 % 以上含有する素錠を、 その素錠の熱膨張能が完全には失われない条件 (即ち、 そ の素錠の熱膨脹能が少なくとも一部残されるような条件) で予備加熱し、 次いで コーティング液を塗布しながら又は塗布した後、 加熱錠剤を熱膨張させることに より、 コーティングの初期に発生した錠剤の表面の荒れが修復されることを見い だし、 本発明を完成させた。  In view of the above problems, the present inventors have conducted intensive studies and as a result, obtained a plain tablet containing 50% or more of a hygroscopic polymer under the condition that the thermal expansion ability of the plain tablet is not completely lost (ie, Pre-heating under the condition that the thermal expansion capacity of the uncoated tablet remains at least partially), and then, during or after the application of the coating liquid, the heated tablet is thermally expanded to generate the initial stage of coating. The present inventors have found that the roughened surface of the prepared tablet is restored, and completed the present invention.
[図面の簡単な説明]  [Brief description of drawings]
図 1は、 実施例 1で得られた素錠の厚み増加量の、 種々の温度における時間推 移を示すグラフの一例である。  FIG. 1 is an example of a graph showing the time transition at various temperatures of the thickness increase of the uncoated tablet obtained in Example 1.
図 2は、 実施例 1で得られた素錠 (水分含有量 5 . 5重量%) の加熱による厚 み増加量の時間推移を示すグラフの一例である。  FIG. 2 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 5.5% by weight) obtained in Example 1 due to heating.
図 3は、 実施例 2で得られた素錠 (水分含有量 3 . 0重量%) の加熱による厚 み増加量の時間推移を示すグラフの一例である。  FIG. 3 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 3.0% by weight) obtained in Example 2 due to heating.
図 4は、 実施例 2で得られた素錠 (水分含有量 3 . 8重量%) の加熱による厚 み増加量の時間推移を示すグラフの一例である。  FIG. 4 is an example of a graph showing the time change of the amount of increase in thickness of the uncoated tablet (water content: 3.8% by weight) obtained in Example 2 due to heating.
図 5は、 実施例 3で得られた素錠 (水分含有量 8 . 0重量%) の加熱による厚 み増加量の時間推移を示すグラフの一例である。  FIG. 5 is an example of a graph showing the time transition of the increase in thickness of the uncoated tablet (water content: 8.0% by weight) obtained in Example 3 due to heating.
図 6は、 実施例 4で製造したコーティング錠剤の外観を示す上面写真の一例で ある。 図 7は、 実施例 4で製造したコーティング錠剤の外観を示す側面写真の一例で ある。 FIG. 6 is an example of a top photograph showing the appearance of the coated tablet produced in Example 4. FIG. 7 is an example of a side photograph showing the appearance of the coated tablet manufactured in Example 4.
図 8は、 実施例 5で製造したコ一ティング錠剤の外観を示す上面写真の一例で ある。  FIG. 8 is an example of a top photograph showing the appearance of the coating tablet produced in Example 5.
図 9は、 比較例 1で製造したコーティング錠剤の外観を示す上面写真の一例で ある。  FIG. 9 is an example of a top photograph showing the appearance of the coated tablet produced in Comparative Example 1.
図 1 0は、 比較例 1で製造したコーティング錠剤の外観を示す側面写真の一例 である。  FIG. 10 is an example of a side photograph showing the appearance of the coated tablet produced in Comparative Example 1.
本発明においては、吸湿性高分子を 5 0重量%以上含有する素錠を対象とする。 このような素錠は熱膨張能を有しているが、 加熱を十分に行うと本来有している 熱膨張能が完全に失われてしまう。 即ち本発明は、 このような素錠を、 その熱膨 張能が完全には失われない条件 (即ち、 その熱膨脹能が少なくとも一部残される ような条件) で予備加熱し、 次いでコーティング液を塗布しながら又は塗布した 後、 錠剤を十分に膨張させるような条件下に保持することにより該錠剤の表面状 態を修復させることを特徴とする、 吸湿性高分子を主成分とするコーティング錠 剤の製造方法に関する。  The present invention is directed to uncoated tablets containing 50% by weight or more of a hygroscopic polymer. Such uncoated tablets have a thermal expansion capability, but if heated sufficiently, the original thermal expansion capability is completely lost. That is, the present invention pre-heats such uncoated tablets under the condition that the thermal expansion ability is not completely lost (that is, the condition that at least a part of the thermal expansion ability is left), and then the coating liquid is heated. A coated tablet containing a hygroscopic polymer as a main component, wherein the surface condition of the tablet is restored by maintaining the tablet under sufficient conditions during or after the application. And a method for producing the same.
また、本発明は、上記の製造方法により得られるコーティング錠剤にも関する。 本発明において、 コーティングとはフィルムコーティング、 糖衣コーティング 等の通常錠剤のコ一ティングに適用可能な公知のコ一ティング方法を指し、 この うち好ましくはフィルムコーティングである。 即ち、 コーティング錠剤としては フィルムコーティング錠剤が好ましい。  The present invention also relates to a coated tablet obtained by the above production method. In the present invention, the coating means a known coating method applicable to coating of ordinary tablets, such as film coating and sugar coating, and among them, film coating is preferable. That is, the coated tablet is preferably a film-coated tablet.
本発明において、 吸湿性高分子(absorbent polymer)とは、 相対湿度 5 0 %の室 温 (2 2〜2 8 ^) 下で、 1週間以内に水分含有量が 1 0重量%以上となる高分 子を意味する。  In the present invention, the term "absorbent polymer" refers to a high-absorbent polymer having a water content of 10% by weight or more within one week under a room temperature (22 to 28 ^) at a relative humidity of 50%. Means molecule.
このような吸湿性高分子としては、 例えば、  As such a hygroscopic polymer, for example,
ァクリル酸系ポリマー (ァクリル酸一ビニルアルコール系ポリマー) メ夕クリル酸系ポリマー  Acrylic acid polymer (acrylic acid-vinyl alcohol polymer) Methacrylic acid polymer
アクリルアミ ド系ポリマー  Acrylamide polymer
ァリルアミン系ポリマー カルボキシメチルセルロース系ポリマー Arylamine-based polymer Carboxymethyl cellulose polymer
フラクトースなどを炭素源として産生するバイオポリマー  Biopolymer that produces fructose etc. as a carbon source
などの重合体が挙げられ、 これらの塩、 ケン化物、 加水分解物も含まれる。 また、 上記重合体には、 それぞれのホモポリマー以外に、 これらのコポリマーや、 これ ら各モノマーとそれらと共重合可能な他のモノマーやグラフト重合可能なポリマ 一とのコポリマーも包含される。 こうしたコポリマーは、 ランダム重合体であつ ても、 ブロック重合体、 グラフト重合体であってもよい。 また、 種々の架橋剤を 用いて常法に従って作成された各重合体の架橋体も含まれる。 And their salts, saponified products and hydrolysates. In addition to the homopolymers, the above-mentioned polymers also include these copolymers, and copolymers of these monomers with other monomers copolymerizable with them and graft-polymerizable polymers. Such a copolymer may be a random polymer, a block polymer, or a graft polymer. In addition, a crosslinked product of each polymer prepared according to a conventional method using various crosslinking agents is also included.
前記の架橋剤としては、 多価ァリル類、 多価ピニル類、 多価エポキシ類、 ハロ エポキシ類、 多価アルコール類、 多価アミン類、 ヒドロキシビニル類等の各種の ものを利用することができる。  As the cross-linking agent, various kinds of polyaryls, polyhydric pinyls, polyhydric epoxies, halo epoxies, polyhydric alcohols, polyhydric amines, hydroxyvinyls and the like can be used. .
共重合可能な他のモノマーとしては、 例えばヒドロキシェチル (メタ) ァクリ レート、 (メ卜キシ) ポリエチレングリコール (メタ) ァクリレート、 ダリセリ ン (メタ) ァクリレート、 グリコシルェチル (メタ) ァクリレート等のアルキル (メタ) ァクリレート類; N , N—ジメチルアクリルアミ ド、 アクリルアミ ド等 のアクリルアミ ド系化合物 ;マレイン酸及びその金属塩、 ィタコン酸及びその金 属塩等のカルボン酸系化合物; 2—アクリルアミドー 2—メチルプロパンスルホ ン酸及びその金属塩、 ビニルスルホン酸及びその金属塩、 スチレンスルホン酸及 びその金属塩等のスルホン酸系化合物;その他 N—ビニルピロリ ドン等を例示で きる。  Other copolymerizable monomers include, for example, alkyl (e.g., hydroxyethyl (meth) acrylate, (methoxy) polyethylene glycol (meth) acrylate, dariserine (meth) acrylate, and glycosylethyl (meth) acrylate. (Meth) acrylates; acrylamide compounds such as N, N-dimethylacrylamide and acrylamide; carboxylic acid compounds such as maleic acid and its metal salts, itaconic acid and its metal salts; 2-acrylamide Examples thereof include sulfonic acid compounds such as 2-methylpropanesulfonic acid and its metal salt, vinylsulfonic acid and its metal salt, styrenesulfonic acid and its metal salt; and N-vinylpyrrolidone.
また、 (メタ) アクリル酸とグラフト重合可能なポリマーとしては、 例えば澱 粉、 カラギーナン、 ァガロース、 カルボキシメチルセルロース等の親水性多糖類 等を例示できる。  Examples of the polymer that can be graft-polymerized with (meth) acrylic acid include starch, carrageenan, agarose, and hydrophilic polysaccharides such as carboxymethyl cellulose.
代表的な架橋剤としては次のものを例示できる。  The following can be exemplified as typical crosslinking agents.
多価ァリル類: N , N—ジァリルアクリルアミド及び N , N—ジァリルメ夕ク リルアミ ド (これ等を 「N , N—ジァリル (メタ) アクリルアミ ド」 と表記する、 以下同じ) 、 ジァリルアミン、 ジァリルメタクリルアミン、 ジァリルフタレート、 ジァリルマレート等の多価ァリル系化合物。  Polyvalent aryls: N, N-diarylacrylamide and N, N-diarylmethylacrylamide (these are referred to as “N, N-diaryl (meth) acrylamide”, the same applies hereinafter), diarylamine, Polyvalent aryl compounds such as diaryl methacrylamine, diaryl phthalate, and diaryl malate;
多価ビニル類: ジビニルベンゼン、 N, N " —メチレンビス (メタ) アクリル アミ ド、 エチレングリコールジ (メタ) ァクリレート及びポリエチレングリコー ルジ (メタ) アタリレート (これ等を 「 (ポリ) エチレングリコールジ (メタ) ァクリレー卜」 と表記する、 以下同じ) 、 (ポリ) プロピレングリコールジ (メ タ) ァクリレート、 トリメタロールプロパントリァクリレート等の多価ビニル系 化合物。 Polyvinyls: divinylbenzene, N, N "-methylenebis (meth) acryl Amide, ethylene glycol di (meth) acrylate and polyethylene glycol di (meth) acrylate (these are referred to as “(poly) ethylene glycol di (meth) acrylate”, the same applies hereinafter), and (poly) propylene glycol (Meta) Polyvalent vinyl compounds such as acrylate and trimetalol propane triacrylate.
多価エポキシ類: (ポリ) エチレングリコールジグリシジルエーテル、 (ポリ) プロピレングリコールジグリシジルエーテル、 グリセリン— 1 , 3—ジグリシジ ルエーテル、 卜リメチロールプロパントリグリシジルエーテル、 (ポリ) グリセ リンポリグリシジルエーテル等のポリエポキシ化合物。  Polyepoxys: (poly) ethylene glycol diglycidyl ether, (poly) propylene glycol diglycidyl ether, glycerin-1,3-diglycidyl ether, trimethylolpropane triglycidyl ether, (poly) glycerin polyglycidyl ether, etc. Polyepoxy compound.
ハロエポキシ類:ェピクロルヒドリン、 α—メチルクロルヒドリン等。  Haloepoxys: epichlorohydrin, α-methylchlorohydrin and the like.
多価アルコール類: (ポリ) グリセリン、 (ポリ) エチレングリコール、 トリ メチロールプロパン、 ペンタエリスリ トール等。  Polyhydric alcohols: (poly) glycerin, (poly) ethylene glycol, trimethylolpropane, pentaerythritol and the like.
多価アミン類:エチレンジァミン等。  Polyvalent amines: ethylenediamine and the like.
本発明で用いられる吸湿性高分子としては、 ポリアリルアミン系吸水性高分子 が好ましく、 さらにポリアリルアミンをェピクロルヒドリンにより架橋重合した 吸水性高分子が好ましく、 特に下記式 (1 )  The hygroscopic polymer used in the present invention is preferably a polyallylamine-based water-absorbing polymer, and more preferably a water-absorbing polymer obtained by crosslinking and polymerizing polyallylamine with epichlorohydrin.
Figure imgf000007_0001
[式中、 (a + b) : cのモル比が 45 : 1〜2 : 1であり、 mは整数を表す] で表される吸水性高分子が好ましい。 式 (1) で表される吸水性高分子は、 例え ば、 特表平 9— 504782号公報 (国際公開 WO 95Z05 1 84号公報) に記載された方法や、 国際公開 WO 00/22008号公報に記載された方法 等に従って得ることができる。
Figure imgf000007_0001
[Wherein the molar ratio of (a + b): c is 45: 1 to 2: 1, and m represents an integer]. The water-absorbing polymer represented by the formula (1) can be prepared, for example, by the method described in Japanese Patent Publication No. 9-504782 (International Publication WO 95Z05184) or the international publication WO 00/22008. Can be obtained according to the method described in, for example.
また、 本発明で用いられる吸湿性高分子としては、 下記 (2) 〜 (9) のポリ マーも好適に使用できる。  Further, as the hygroscopic polymer used in the present invention, the following polymers (2) to (9) can also be suitably used.
ポリマー (2) は下記式  The polymer (2) has the following formula
Figure imgf000008_0001
で表される反復単位を有することを特徴とするポリマー、 又はそのコポリマーで ある。 式中、 nは整数であり、 Rはそれぞれ独立に H又は低級アルキル基 (例え ば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチ ルァミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリー ル基 (例えば、 1から 12の炭素原子を含むァリール基 (例えば、 フエニル基、 ナフチル基など) ) である。
Figure imgf000008_0001
Or a copolymer thereof having a repeating unit represented by the formula: In the formula, n is an integer, and R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as an ethylamino group). An alkylamino group containing 5 carbon atoms) or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)).
ポリマー (3) は下記式  The polymer (3) has the following formula
Figure imgf000008_0002
で表される反復単位を有することを特徴とするポリマー、 又はそのコポリマーで ある。 式中、 nは整数であり、 Rはそれぞれ独立に H又は低級アルキル基 (例え ば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチ ルァミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリー ル基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フエニル基、 ナフチル基など) ) であり、 X はそれぞれ交換可能な負に荷電した対イオンで ある。
Figure imgf000008_0002
Or a copolymer thereof having a repeating unit represented by the formula: In the formula, n is an integer, and R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as an ethylamino group). Alkylamino group containing 5 carbon atoms), or aryl (Eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)), and X is an exchangeable negatively charged counterion.
上記ポリマ一 (3 ) のコポリマーの例としては、 下記式  Examples of the copolymer of the above polymer (3) include the following formula:
Figure imgf000009_0001
[式中、 nは整数であり、 Rはそれぞれ独立に H又は低級アルキル基 (例えば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチルァ ミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フエニル基、 ナフ チル基など) ) であり、 X はそれぞれ交換可能な負に荷電した対イオンである] で表される第 1の反復単位と、 さらに下記式
Figure imgf000009_0001
Wherein n is an integer, and R is independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 5 such as an ethylamino group). An alkylamino group containing 1 to 12 carbon atoms) or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)); Is a charged counterion], and the following formula
Figure imgf000009_0002
Figure imgf000009_0002
[式中、 nはそれぞれ独立に整数であり、 Rはそれぞれ独立に H又は低級アルキ ル基 (例えば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例 えば、 ェチルァミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フ ェニル基、 ナフチル基など.) ) である] で表される第 2の反復単位とを有するこ とを特徴とするポリマー (ポリマー (4 ) ) である。 [Wherein, n is each independently an integer, and R is each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, an ethylamino group). An alkylamino group containing 1 to 5 carbon atoms) or an aryl group (for example, an aryl group containing 1 to 12 carbon atoms (for example, phenyl, naphthyl, etc.)). (Polymer (4)) characterized by having a second repeating unit.
ポリマー (5 ) は、 下記式
Figure imgf000010_0001
で表される反復単位を有することを特徴とするポリマ一、 又はそのコポリマーで ある。 式中、 nは整数であり、 Rは H又は低級アルキル基 (例えば、 1から 5の 炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチルァミノ基のよ うな 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基(例えば、フエニル基、ナフチル基など)) である。
The polymer (5) has the following formula
Figure imgf000010_0001
Or a copolymer thereof having a repeating unit represented by the following formula: Wherein n is an integer, R is H or a lower alkyl group (eg, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (eg, containing 1 to 5 carbon atoms such as an ethylamino group) An alkylamino group) or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (eg, a phenyl group, a naphthyl group, etc.)).
上記ポリマー (3 ) のコポリマーの別の例としては、 下記式  As another example of the copolymer of the polymer (3), the following formula:
Figure imgf000010_0002
Figure imgf000010_0002
[式中、 nは整数であり、 Rは H又は低級アルキル基 (例えば、 1から 5の炭素 原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチルァミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリール基 (例えば、 1か ら 1 2の炭素原子を含むァリール基 (例えば、 フエニル基、 ナフチル基など) ) ] で表される第 1の反復単位と、 さらに下記式 Wherein n is an integer, R is H or a lower alkyl group (eg, an alkyl group containing 1-5 carbon atoms), an alkylamino group (eg, 1-5 carbon atoms such as an ethylamino group) An alkyl group containing 1 to 12 carbon atoms (for example, an aryl group containing 1 to 12 carbon atoms (for example, a phenyl group, a naphthyl group, etc.)) and a first repeating unit represented by the following formula:
X"  X "
(6)(6)
Figure imgf000010_0003
Figure imgf000010_0003
[式中、 nはそれぞれ独立に整数であり、 Rは H又は低級アルキル基 (例えば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチルァ ミノ基のような 1から 5の炭素原子を含むアルキルアミノ基) 、 又はァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フエニル基、 ナフ チル基など) ) である] で表される第 2の反復単位とを有することを特徴とする ポリマー (ポリマー (6 ) ) 。 Wherein n is independently an integer; R is H or a lower alkyl group (eg, an alkyl group containing 1 to 5 carbon atoms); an alkylamino group (eg, 1 to 5 such as an ethylamino group); An alkylamino group containing a carbon atom) or an aryl group (For example, an aryl group containing 1 to 12 carbon atoms (for example, phenyl group, naphthyl group, etc.)). 6))).
ポリマー (7 ) は下記式  The polymer (7) has the following formula
X
Figure imgf000011_0001
で表される反復単位を有することを特徴とするポリマー、 又はそのコポリマーで ある。 式中、 nは整数であり、 ェと R 2はそれぞれ独立に H又は低級アルキル基 (例えば、 1から 5の炭素原子を含むアルキル基) 、 アルキルアミノ基 (例えば、 ェチルァミノ基のような 1から 5の炭索原子を含むアルキルアミノ基) 、 又はァ リール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フエニル 基、 ナフチル基など) ) であり、 X はそれぞれ交換可能な負に荷電した対ィォ ンである。
X
Figure imgf000011_0001
Or a copolymer thereof having a repeating unit represented by the formula: In the formula, n is an integer, and R and R 2 are each independently H or a lower alkyl group (for example, an alkyl group containing 1 to 5 carbon atoms), an alkylamino group (for example, 1 to 4 such as ethylamino group). An alkylamino group containing 5 carbon atoms, or an aryl group (eg, an aryl group containing 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)), and X is each interchangeable This is a negatively charged pair.
上記ポリマー (7 ) の内、 好ましいポリマーは、 式中の R】又は R 2の少なくと も 1つが水素である、 ポリマーである。 Of the polymer (7), preferred polymers are also one and less of R ## or R 2 in the formula is a hydrogen, a polymer.
ポリマー (8 ) は下記式  The polymer (8) has the following formula
Figure imgf000011_0002
で表される反復単位を有することを特徴とするポリマー、 或いはそのコポリマー である。 式中、 nは整数であり、 1^と R 2はそれぞれ独立に H又は 1から 2 0の 炭素原子を含むアルキル基、 アルキルアミノ基 (例えば、 ェチルァミノ基のよう な 1から 5の炭素原子を含むアルキルアミノ基) 、 又は 1から 1 2の原子を含む ァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フエ二 ル基、 ナフチル基など) ) である,
Figure imgf000011_0002
Or a copolymer thereof having a repeating unit represented by the formula: In the formula, n is an integer, and 1 ^ and R 2 are each independently H or an alkyl group containing 1 to 20 carbon atoms, an alkylamino group (for example, 1 to 5 carbon atoms such as ethylamino group). Alkyl groups containing 1 to 12 atoms (eg, aryl groups containing 1 to 12 carbon atoms) (eg, phenyl Group, naphthyl group, etc.))
ポリマー (9 ) は下記式  The polymer (9) has the following formula
X"  X "
Figure imgf000012_0001
で表される反復単位を有することを特徴とするポリマー、 又はそのコポリマーで ある。 式中、 nは整数であり、 !^ェと R 2と R 3はそれぞれ独立に H又は 1から 2 0の炭素原子を含むアルキル基、 アルキルアミノ基 (例えば、 ェチルァミノ基の ような 1から 5の炭素原子を含むアルキルアミノ基) 、 又は 1から 1 2の原子を 含むァリール基 (例えば、 1から 1 2の炭素原子を含むァリール基 (例えば、 フ ェニル基、 ナフチル基など) ) であり、 X はそれぞれ交換可能な負に荷電した 対イオンである。
Figure imgf000012_0001
Or a copolymer thereof having a repeating unit represented by the formula: Where n is an integer and! R and R 2 and R 3 are each independently H or an alkyl group containing 1 to 20 carbon atoms, an alkylamino group (for example, an alkylamino group containing 1 to 5 carbon atoms such as an ethylamino group), Or an aryl group containing from 1 to 12 atoms (eg, an aryl group containing from 1 to 12 carbon atoms (eg, phenyl, naphthyl, etc.)), where X is each exchangeable negatively charged It is a counter ion.
上記の各ポリマーにおいて、 負に荷電した対イオンは、 有機イオンでも、 無機 イオンでも或いはそれらの組み合わせでも良い。 本発明の用途に適する無機ィォ ンは、 ハロゲン化物 (特に、 塩化物) 、 リン酸塩、 亜リン酸塩、 炭酸塩、 量炭酸 塩、 硫酸塩、 硫酸水素塩、 水酸化物、 硝酸塩、 過硫酸塩、 亜硫酸塩及び硫化物の 各イオンである。 好ましい有機イオンとしては、 酢酸塩、 ァスコルビン酸塩、 安 息香酸塩、 クェン酸塩、 二水素化クェン酸塩、 一水素化クェン酸塩、 シユウ酸塩、 コハク酸塩、 酒石酸塩、 タウロコール酸塩、 グリココール酸塩、 及びコール酸塩 の各イオンである。  In each of the above polymers, the negatively charged counterion may be an organic ion, an inorganic ion, or a combination thereof. Inorganic ions suitable for use in the present invention include halides (especially chlorides), phosphates, phosphites, carbonates, carbonates, sulfates, hydrogensulfates, hydroxides, nitrates, These are persulfate, sulfite and sulfide ions. Preferred organic ions include acetate, ascorbate, benzoate, citrate, dihydrogenate, monohydrogenate, oxalate, succinate, tartrate, taurocholate Salt, glycocholate, and cholate ions.
また、 吸水性高分子 (super- absorbent polymer)とは、 l gで 1 0 m L以上の 水を吸収して、 流動性のないゲル状に変化するとともに、 多少の圧力を加えても 吸収した水を逃がさない強い保水力を示す高分子を意味する。 吸水性高分子とし ては、 前記の吸湿性高分子として例示された高分子を例示することができる。 本発明の吸湿性高分子を 5 0重量%以上含有する素錠は、 直接粉末圧縮法や間 接粉末圧縮法のような常法により製造することができる。 また、 錠剤化において は、 通常使用される各種添加剤の中から、 好適な賦形剤、 崩壊剤、 流動化剤、 結 合剤、 滑沢剤、 着色剤、 香料等の添加剤を本発明の目的を阻害しない範囲におい て含有してもよい。 Also, a super-absorbent polymer is a substance that absorbs more than 10 mL of water by lg, changes into a gel without fluidity, and absorbs water even if a slight pressure is applied. Means a polymer that exhibits a strong water retention capacity that does not escape. Examples of the water-absorbing polymer include the polymers exemplified as the hygroscopic polymer. An uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention can be produced by a conventional method such as a direct powder compression method or an indirect powder compression method. In tableting, a suitable excipient, disintegrant, fluidizing agent, Additives such as a mixture, a lubricant, a coloring agent, and a fragrance may be contained within a range not to impair the object of the present invention.
含有する流動化剤の量は、 素錠の全重量に対して好ましくは 1重量%以下であ る。 含有する結合剤の量は、 素錠の全重量に対して好ましくは 2 0重量%以下で ある。 含有する滑沢剤の量は、 素錠の全重量に対して好ましくは 0 . 0 5〜 1重 量%である。  The amount of the fluidizing agent contained is preferably 1% by weight or less based on the total weight of the uncoated tablet. The amount of the binder contained is preferably not more than 20% by weight based on the total weight of the uncoated tablet. The amount of the lubricant contained is preferably 0.05 to 1% by weight based on the total weight of the uncoated tablet.
賦形剤としては、 例えば、 結晶セルロース、 低置換度ヒドロキシプロピルセル ロースなどのセルロース又はセルロース誘導体; トウモロコシデンプン、 デキス トリンなどのデンプン又はデンプン誘導体;乳糖、 白糖、 D—マンニト一ルなど の糖又は糖アルコール;乾燥水酸化アルミニウムゲル、 沈降炭酸カルシウム、 合 成ケィ酸アルミニウム、 メタケイ酸アルミン酸マグネシウム、 軽質無水ケィ酸、 リン酸水素力ルシゥムなどの無機系賦形剤を挙げることができる。  Examples of the excipient include cellulose or cellulose derivatives such as crystalline cellulose and low-substituted hydroxypropyl cellulose; starch or starch derivatives such as corn starch and dextrin; sugars such as lactose, sucrose, and D-mannitol; Sugar alcohols; inorganic excipients such as dried aluminum hydroxide gel, precipitated calcium carbonate, synthetic aluminum silicate, magnesium aluminate metasilicate, light anhydrous silicic acid, hydrogen phosphate and the like.
結合剤としては、 例えば、 ヒドロキシプロピルセルロース、 低置換度ヒドロキ シプロピルセルロース、 メチルセルロース、 ヒドロキシプロピルメチルセルロー ス、 カルポキシメチルェチルセルロースなどのセルロース又はセルロース誘導 体; トウモロコシデンプンなどのデンプン又はこれをひ化したもの; ヒドロキシ プロピルスターチなどのデンプン誘導体;プルラン、 ポリビニルアルコール、 ポ リビニルピロリ ドン、 アラビアゴム、 ゼラチン、 トラガントなどを挙げることが できる。  Examples of the binder include cellulose or cellulose derivatives such as hydroxypropylcellulose, low-substituted hydroxypropylcellulose, methylcellulose, hydroxypropylmethylcellulose, and carboxymethylethylcellulose; starch such as corn starch; Starch derivatives such as hydroxypropyl starch; pullulan, polyvinyl alcohol, polyvinylpyrrolidone, acacia, gelatin, tragacanth, and the like.
崩壊剤としては、例えば、 カルメロース又はこのナトリゥム塩やカルシウム塩、 クロスカルメロースナトリウムなどのセルロース誘導体; コムギデンプン、 カル ボキシメチルスターチナトリゥムなどのデンプン又はデンプン誘導体; アルギン 酸ナトリゥムなどを挙げることができる。  Examples of the disintegrating agent include carmellose or a cellulose derivative such as sodium salt or calcium salt thereof and croscarmellose sodium; starch or a starch derivative such as wheat starch and carboxymethyl starch sodium; sodium alginate; Can be.
流動化補助剤としては、 例えば、 硬化油、 ポリオキシエチレン硬化ヒマシ油、 ステアリン酸ポリオキシル、 ポリオキシエチレンポリオキシプロピレングリコー ル、 ポリソルべ一ト、 セスキォレイン酸ソルビタンなどの無水ソルビトールの脂 肪酸エステル、 モノステアリン酸グリセリン、 ラウロマクロゴールなどを挙げる ことができる。  Examples of the fluidization aid include hydrogenated oil, polyoxyethylene hydrogenated castor oil, polyoxyl stearate, polyoxyethylene polyoxypropylene glycol, polysorbate, and fatty acid esters of anhydrous sorbitol such as sorbitan sesquioleate; Glycerin monostearate, lauromacrogol and the like can be mentioned.
滑沢剤としては、 例えば、 ステアリン酸、 ステアリン酸マグネシウム、 ステア リン酸カルシウムなどの高級脂肪酸及びその金属塩; タルク、 ラウリル硫酸ナト リウム、 ショ糖脂肪酸エステル、 コロイ ドシリカなどを挙げることができる。 本発明の吸湿性高分子を 5 0重量%以上含有する素錠は、 各成分を混合し打錠 することにより製造することができる。 本発明で用いられる錠剤製法としては特 に制限はなく、 直接粉末圧縮法、 半直接粉末圧縮法、 乾式顆粒圧縮法、 湿式顆粒 圧縮法などの公知の方法を好適に使用することができる。 Lubricants include, for example, stearic acid, magnesium stearate, stearic Higher fatty acids such as calcium phosphate and metal salts thereof; talc, sodium lauryl sulfate, sucrose fatty acid ester, colloid silica and the like. The uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention can be produced by mixing each component and tableting. The tablet manufacturing method used in the present invention is not particularly limited, and known methods such as a direct powder compression method, a semi-direct powder compression method, a dry granulation compression method, and a wet granulation compression method can be suitably used.
本発明の吸湿性高分子を 5 0重量%以上含有する素錠は、 水分含有量が 1 0重 量%以下であることが、 熱膨張能が完全に失われない条件で予備加熱する上で好 ましい。  An uncoated tablet containing 50% by weight or more of the hygroscopic polymer of the present invention should have a water content of 10% by weight or less for preheating under the condition that the thermal expansion ability is not completely lost. It is good.
本発明の吸湿性高分子を 5 0 %以上含有する素錠は、 具体的には例えば、 特開 平 1 0— 3 3 0 2 6 9号公報 (国際公開 W〇 9 8 4 4 9 3 3号公報) に記載 された方法や、 国際公開 WO 0 0 Z 2 2 0 0 8号公報に記載された方法等に従 つて製造することができる。  The uncoated tablet containing 50% or more of the hygroscopic polymer of the present invention is specifically described in, for example, Japanese Patent Application Laid-Open No. H10-33069 (International Publication WO98444993). Publication), the method described in International Publication WO 00Z2208, and the like.
本発明でコーティングに使用するコーティング剤には特に制限はなく、 通常錠 剤のコーティングに用いられるコーティング剤を使用することができる。 例えば フィルムコーティング剤は、 精製水を溶媒としてフィルム基剤を溶解し、 これに 滑沢剤、 遮光剤、 色素などを分散させるなどして、 固形分と水とを混合すること により得ることができる。  The coating agent used for coating in the present invention is not particularly limited, and a coating agent usually used for coating tablets can be used. For example, a film coating agent can be obtained by dissolving a film base using purified water as a solvent, dispersing a lubricant, a light-blocking agent, a dye, and the like, and mixing the solid content with water. .
また、 本発明で使用するコーティング剤は、 固形分として可塑剤、 滑沢剤、 遮 光剤、 色素などの各種添加剤を含んでいてもよい。 前記固形分の濃度は、 通常 1 〜 2 0重量%である。  Further, the coating agent used in the present invention may contain various additives such as a plasticizer, a lubricant, a light shielding agent, and a pigment as a solid content. The concentration of the solid content is usually 1 to 20% by weight.
前記のコーティング剤に用いられるフィルム基剤としては、 一般的に添加され ているものを使用することができ、 錠剤の目的に合わせて胃溶性フィルムコーテ ィング基剤や腸溶性又は徐放性フィルムコーティング基剤等を適宜選択すること ができる。  As the film base used in the above-mentioned coating agent, those generally added can be used. Depending on the purpose of the tablet, a gastric film coating base or an enteric or sustained release film coating can be used. The base and the like can be appropriately selected.
胃溶性フィルムコーティング基剤としては、 例えば、 ヒドロキシプロピルセル ロース、 ヒドロキシプロピルメチルセルロースなどのセルロース誘導体;ポリビ ニールァセ夕一ルジェチルアミノアセテー卜、 アミノアルキルメタァクリレート コポリマー E 〔オイドラギット E (商品名) 、 ロームフアルマ社〕 、 ポリビニル ピロリ ドンなどの合成高分子;デキストリン、 プルラン、 ゼイン、 アルギン酸ナ トリウム、 ゼラチン、 白糖などを挙げることができる。 Examples of the gastrosoluble film coating base include cellulose derivatives such as hydroxypropylcellulose and hydroxypropylmethylcellulose; polyvinylacetate ylethylethyl acetate, aminoalkyl methacrylate copolymer E [Eudragit E (trade name) , ROHM FALMA, Inc. Synthetic polymers such as pyrrolidone; dextrin, pullulan, zein, sodium alginate, gelatin, sucrose and the like.
腸溶性又は徐放性フィルムコーティング基剤としては、 例えば、 ェチルセル口 ース、 ヒドロキシプロピルメチルセルロースフタレート、 ヒドロキシプロピルメ チルセルロースアセテートサクシネート、 カルボキシメチルェチルセルロース、 酢酸フ夕ル酸セルロースなどのセルロース誘導体; メタァクリル酸コポリマー L 又は L D 〔オイ ドラギットし、 L— 3 0 D 5 5、 (商品名) 、 ロームフアルマ社〕 、 アミノアルキルァクリレートコポリマー R S 〔オイドラギット R S (商品名) 、 ロームフアルマ社〕 などのアクリル酸系高分子;セラックなどの天然物などを挙 げることができる。  Examples of the enteric or sustained release film coating base include cellulose derivatives such as ethylcellulose, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, carboxymethylethylcellulose, and cellulose acetate fluorate. Acrylic such as methacrylic acid copolymer L or LD (Eudragit L-30D55, (trade name), Rohm Pharma Co.), aminoalkyl acrylate copolymer RS (Eudragit RS (trade name), Rohm Pharma Co.) Acid-based polymers; natural products such as shellac;
これらを単独で、又は 2種以上を混合して用いることができる。 これらの中で、 セルロース誘導体が好ましく、 更にヒドロキシプロピルセルロース、 ヒドロキシ プロピルメチルセルロースがより好ましい。 フィルム基剤の使用量は特別な値と する必要はなく、 フィルム層に対して 5 0重量%以上とすればよい。  These can be used alone or in combination of two or more. Of these, cellulose derivatives are preferred, and hydroxypropyl cellulose and hydroxypropylmethyl cellulose are more preferred. The use amount of the film base does not need to be a special value, and may be 50% by weight or more based on the film layer.
前記のコーティング剤に用いられる可塑剤としては、例えば、マクロゴール(ポ リエチレングリコール) 、 クェン酸トリエチル、 トリァセチン、 中鎖脂肪酸トリ グリセリ ド、 グリセリンなどを挙げることができる。 可塑剤の添加量は、 コーテ ィング液中の全固形分に対して通常 5 0重量%未満である。  Examples of the plasticizer used in the coating agent include macrogol (polyethylene glycol), triethyl citrate, triacetin, medium-chain fatty acid triglyceride, and glycerin. The amount of the plasticizer added is usually less than 50% by weight based on the total solids in the coating solution.
前記のコーティング剤に用いられる滑沢剤としては、 例えば、 タルク、 ステア リン酸、 ステアリン酸マグネシウム、 ショ糖脂肪酸エステルなどを挙げることが できる。滑沢剤の添加量は、コ一ティング液中の全固形分に対して通常 5 0重量% 未満である。  Examples of the lubricant used in the above coating agent include talc, stearic acid, magnesium stearate, and sucrose fatty acid ester. The amount of lubricant added is usually less than 50% by weight, based on the total solids in the coating liquid.
前記のコーティング剤に用いられる遮光剤又は色素としては、 例えば、 酸化チ タン、 黄色三二酸化鉄、 赤色三二酸化鉄、 黒色三二酸化鉄などの酸化金属、 夕一 ル系色素などがあげられる。 遮光剤又は色素の添加量は、 コーティング液中の全 固形分に対して通常 5 0重量%未満である。  Examples of the light-shielding agent or pigment used in the coating agent include metal oxides such as titanium oxide, yellow sesquioxide, red sesquioxide, and black sesquioxide, and evening dyes. The addition amount of the light-shielding agent or the dye is usually less than 50% by weight based on the total solid content in the coating solution.
本発明で用いられるコ一ティング液の塗布方法は、 特に制限はなく公知の方法 を好適に使用することができるが、 市販のコーティング装置を用い、 スプレーに よって素錠を被覆することが好ましい。 コーティング液の塗布量も特に制限はな いが、 皮膜量が素錠に対して 1〜 1 0重量%となる量であることが好ましい。 また、 上記の皮膜量が素錠に被覆され、 コーティングの初期に発生した錠剤の 表面の荒れが修復された以後、 十分な強度 (フィルムコーティング剤であればフ イルム強度) が得られれば、 引き続き同一又は異なるコーティング液を常法によ り塗布することができる。 The method of applying the coating liquid used in the present invention is not particularly limited, and a known method can be suitably used. However, it is preferable to coat the uncoated tablet by spraying using a commercially available coating apparatus. There is no particular limitation on the amount of coating liquid applied. However, it is preferable that the amount of the coating be 1 to 10% by weight based on the uncoated tablet. In addition, after the uncoated tablet is coated with the above film amount and the surface of the tablet is repaired at the initial stage of coating, if sufficient strength (film strength for film coating agent) is obtained, The same or different coating liquids can be applied by conventional methods.
本発明の製造方法におけるコーティングは、 前記の吸湿性高分子を 5 0 %以上 含有する素錠を、 その熱膨張能が完全には失われない条件 (即ち、 その熱膨脹能 が少なくとも一部残されるような条件) で予備加熱し、 次いでコーティング液を 塗布しながら又は塗布した後、 錠剤を十分に膨張させるような条件下に保持する ことにより行うことができる。 ここで、 熱膨張とは、 加熱によって引き起こされ る、 錠剤の厚み増加を伴う変形を意味する。  The coating in the production method of the present invention is performed under the condition that the thermal expansion capacity of the uncoated tablet containing 50% or more of the hygroscopic polymer is not completely lost (that is, at least a part of the thermal expansion capacity is left). Under such conditions), and then, while or after applying the coating solution, maintaining the tablet under conditions such that the tablet is sufficiently expanded. Here, the thermal expansion means deformation accompanied by an increase in the thickness of the tablet caused by heating.
また、 上記の素錠の熱膨張能が完全には失われない条件、 およびその後の錠剤 を十分に膨張させるような条件は、 加熱による錠剤 (素錠) の厚み増加量を測定 することにより求めることができる。 加熱による錠剤の厚み増加量は、 錠剤を所 定の温度 (例えば 3 0で、 4 0で、 5 0で、 6 0 °C、 7 0で、 8 0 など) に保 持し、 所定の時間毎 (例えば 5分毎、 1 0分毎など) に錠剤の厚みを測定し、 加 熱前の錠剤の厚みと比較することにより求めることができる。  The conditions under which the thermal expansion capacity of the uncoated tablet is not completely lost, and the conditions under which the tablet is sufficiently expanded thereafter, are determined by measuring the increase in the thickness of the uncoated tablet (heating tablet) due to heating. be able to. The amount of increase in the thickness of the tablet due to heating can be determined by maintaining the tablet at a specified temperature (for example, at 30, 40, 50, 60 ° C, 70, 80, etc.) for a predetermined period of time. It can be obtained by measuring the thickness of the tablet every time (for example, every 5 minutes, every 10 minutes, etc.) and comparing it with the thickness of the tablet before heating.
錠剤を十分に膨張させるような条件とは、 上記のようにして測定した錠剤の厚 み増加量が最大に近くなる条件であり、 コーティング液を塗布している時又は塗 布した後、 或いはその両者について適切な温度を設定しなければならない。 具体 的には、 錠剤をその条件下に一定時間保持したときの厚み増加量が、 素錠の厚み の 0 . 5 %以上となる条件であり、 好ましくは 2 . 5 %以上となる条件であり、 さらに好ましくは 5 . 0 %以上となる条件である。  The conditions under which the tablet is sufficiently expanded are conditions under which the increase in the thickness of the tablet measured as described above is close to the maximum, and when the coating liquid is applied or after the coating liquid is applied, or when the coating liquid is applied. Appropriate temperatures must be set for both. Specifically, the condition is such that the amount of increase in thickness when the tablet is held for a certain time under the condition is 0.5% or more of the thickness of the uncoated tablet, preferably 2.5% or more. More preferably, the condition is 5.0% or more.
錠剤を十分に膨張させるような条件における錠剤温度は、 通常は錠剤をその温 度で 2 0分間保持したときの厚み増加量が素錠の厚みの 0 . 5 %以上となる温度 であり、 好ましくは前記の厚み増加量が素錠の厚みの 2 . 5 %以上となる温度で あり、 さらに好ましくは前記の厚み増加量が素錠の厚みの 5 . 0 %以上となる温 度である。  The tablet temperature under such conditions that the tablet is sufficiently expanded is usually a temperature at which the amount of increase in thickness when the tablet is held at that temperature for 20 minutes is 0.5% or more of the thickness of the uncoated tablet, and is preferable. Is a temperature at which the above-mentioned increase in thickness becomes 2.5% or more of the thickness of the uncoated tablet, and more preferably a temperature at which the above-mentioned thickness increase becomes 5.0% or more of the thickness of the uncoated tablet.
錠剤を十分に膨張させるような条件における錠剤温度としては、 コーティング 液を塗布している時は錠剤温度 4 0 °C以上、 コーティング液を塗布した後は錠剤 温度 5 0で以上に保持されることが好ましい。 The tablet temperature under conditions that cause the tablet to swell sufficiently is coating It is preferable that the tablet temperature is maintained at 40 ° C. or higher when the liquid is applied, and the tablet temperature is maintained at 50 or higher after the coating liquid is applied.
吸湿性高分子がポリアリルアミン系高分子である場合、 錠剤を十分に膨張させ るような条件における錠剤温度は、 コ一ティング液を塗布している時は錠剤温度 4 0 :〜7 0 :、 コーティング液を塗布した後は錠剤温度 5 5 〜 8 5 で保持 されることが好ましい。  When the hygroscopic polymer is a polyallylamine-based polymer, the tablet temperature under conditions that sufficiently swell the tablet is as follows: when the coating liquid is applied, the tablet temperature is 40: to 70: After the coating liquid is applied, the tablet temperature is preferably maintained at 55 to 85.
錠剤を十分に膨張させるような条件下に保持する時間は、 錠剤表面の平滑度が 目的とする状態に達するまでの時間であり、 通常 3 0分間以上であり、 好ましく は 6 0分間以上であり、 さらに好ましくは 9 0分間以上である。 前述のように、 十分な強度 (フィルムコーティング剤であればフィルム強度) が得られれば、 引 き続き同一又は異なるコーティング液を常法により塗布することができるので、 当該錠剤をコーティングする目的 (錠剤表面の平滑度向上以外の目的としては、 主薬の安定性の向上、 使用性の向上、 主薬の放出時間の制御など) を十分満たす 以上の時間行うことができる。  The time required to maintain the tablet under sufficient conditions to swell the tablet is the time required for the smoothness of the tablet surface to reach the desired state, and is usually 30 minutes or more, and preferably 60 minutes or more. More preferably, it is 90 minutes or more. As mentioned above, if sufficient strength (film strength in the case of a film coating agent) is obtained, the same or different coating liquid can be applied in a conventional manner. For purposes other than surface smoothness improvement, improvement of stability of the active substance, improvement of usability, control of release time of the active substance, etc.) can be performed for a time longer than sufficient.
吸湿性高分子がポリアリルアミン系高分子である場合、 コーティング液を塗布 しながら錠剤を十分に膨張させるような条件は、 通常、 錠剤温度 4 0で〜 6 0 °C で 6 0分間〜 4 0 0分間であり、 錠剤温度 4 0で〜 6 0 ^で 1 2 0分間〜 4 0 0 分間が好ましい。  When the hygroscopic polymer is a polyallylamine-based polymer, conditions for sufficiently swelling the tablet while applying the coating liquid are usually at a tablet temperature of 40 to 60 ° C for 60 minutes to 40 ° C. 0 minutes, and preferably 120 to 400 minutes at a tablet temperature of 40 to 60 ^.
また、 吸湿性高分子がポリアリルアミン系高分子である場合、 錠剤にコーティ ング液を塗布した後、 十分に膨張させるような条件は、 通常、 錠剤温度 5 5で〜 8 5でで 1 0分間以上であり、 錠剤温度 5 5 〜 8 5 t:で 3 0分間以上が好まし く、 さらに錠剤温度 6 0 :〜 8 0でで 3 0分間以上が好ましい。  In addition, when the hygroscopic polymer is a polyallylamine-based polymer, the conditions under which the tablet is coated with a coating liquid and then sufficiently swelled are usually at a tablet temperature of 55 to 85 at a temperature of 10 to 10 minutes. The tablet temperature is preferably at least 30 minutes at a tablet temperature of 55 to 85 t :, and more preferably at least 30 minutes at a tablet temperature of 60 to 80.
素錠をその熱膨張能が完全には失われない条件で予備加熱するとは、 予備加熱 した後の錠剤 (素錠) の厚み増加量が、 錠剤を十分に膨張させるような条件下に 保持したときの錠剤の厚み増加量の 3 Z 5以下となる条件で予備加熱することを 意味し、 予備加熱した後の錠剤の厚み増加量が、 錠剤を十分に膨張させるような 条件下に保持したときの錠剤の厚み増加量の 2 / 5以下である条件で予備加熱す ることが好ましく、 さらに予備加熱した後の錠剤の厚み増加量が、 錠剤を十分に 膨張させるような条件下に保持したときの錠剤の厚み増加量の 1ノ 5以下である 条件で予備加熱することが好ましい。 Preheating the uncoated tablet under the condition that its thermal expansion capacity is not completely lost means that the tablet (uncoated tablet) after preheating is kept under such conditions that the thickness increase of the uncoated tablet causes the tablet to expand sufficiently. Means preheating under the condition that the thickness increase of the tablet at the time is 3 Z 5 or less, and when the thickness increase of the tablet after preheating is maintained under conditions that allow the tablet to expand sufficiently Preheating is preferably performed under conditions that are 2/5 or less of the thickness increase of the tablet, and when the thickness increase of the tablet after preheating is maintained under conditions that allow the tablet to expand sufficiently. 1 to 5 or less of the thickness increase of tablets It is preferable to preheat under the conditions.
吸湿性高分子がポリアリルアミン系吸水性高分子である場合、 素錠をその熱膨 張能が完全には失われない条件で予備加熱するにあたっては、 錠剤温度が 4 0で 〜6 0 ^に達するまで予備加熱するのが好ましい。  When the hygroscopic polymer is a polyallylamine-based water-absorbing polymer, when pre-heating the uncoated tablet under the condition that its thermal expansion capacity is not completely lost, the tablet temperature should be reduced to ~ 60 ^ at a tablet temperature of 40. It is preferred to preheat until reaching.
吸湿性高分子がポリアリルアミン系高分子である場合、 素錠をその熱膨張能が 完全には失われない条件で予備加熱する際の所要時間は、 通常 5〜6 0分間程度 であり、 好ましくは 5〜2 0分間である。 この場合の予備加熱は、 給気温 5 0〜 7 0でで行うのが好ましい。  When the hygroscopic polymer is a polyallylamine-based polymer, the time required for preheating the uncoated tablet under the condition that its thermal expansion capacity is not completely lost is usually about 5 to 60 minutes, and is preferable. Is 5 to 20 minutes. The preheating in this case is preferably performed at a supply air temperature of 50 to 70.
熱膨張能が完全には失われない範囲で素錠を予備加熱するためには、 素錠の水 分含有量は、 錠剤の形状や硬度が著しく変化しない範囲内で、 錠剤の厚み増加量 が保持温度によって異なるような量であることが好ましレ^例えば、錠剤を 5 0 で 1 0分間保持したときの厚み増加量が 8 0 で 1 0分間保持した時の厚み増加 量の 1 Z 2以下であることが好ましい。  In order to preheat the uncoated tablet within a range in which the thermal expansion capacity is not completely lost, the water content of the uncoated tablet must be within the range where the shape and hardness of the tablet do not significantly change, and the thickness increase of the tablet is limited. It is preferable that the amount varies depending on the holding temperature.For example, the thickness increase when the tablet is held at 50 for 10 minutes is 1 Z 2 of the thickness increase when the tablet is held at 80 and 10 minutes. The following is preferred.
吸湿性高分子がポリアリルアミン系高分子である場合、 素錠の水分含有量は、 1 0 5 一 3時間の乾燥減量法による水分含量が 3重量%以上 1 0重量%以下で あることが好ましく、 さらに、 3重量%以上 8重量%以下であることが好ましい。 素錠の水分含有量を調節する方法としては特に制限はないが、 原料の吸湿性高 分子及び各種添加剤を予め所望の水分含有量に調節した状態で混合し、 打錠する 方法が最も簡便である。 他に、 素錠を製造した後、 調湿した環境に保存する方法 や、 真空乾燥法などの通常用いられる乾燥方法によって乾燥する方法もあるが、 この場合は熱膨張するような熱が錠剤にかからないように注意する必要がある。 錠剤の水分含有量は、 例えば乾燥減量法により測定することができ、 その測定 条件としては、 1 0 5で— 3時間が好ましい。  When the hygroscopic polymer is a polyallylamine-based polymer, the water content of the uncoated tablet is preferably from 3% by weight to 10% by weight based on a drying loss method for 105 hours. It is more preferable that the content be 3% by weight or more and 8% by weight or less. There is no particular limitation on the method of adjusting the water content of the uncoated tablet, but the simplest method is to mix the raw material hygroscopic polymer and various additives in a state where the water content is adjusted in advance to the desired water content, and then press the tablet. It is. Other methods include manufacturing uncoated tablets and storing them in a conditioned environment, or drying them using a commonly used drying method such as a vacuum drying method. Care must be taken to avoid this. The water content of the tablet can be measured by, for example, a loss on drying method, and the measurement condition is preferably 105 to 3 hours.
尚、 素錠を保存する際は、 吸湿を防止するために、 防湿包装等を考慮する必要 がある。  When storing uncoated tablets, it is necessary to consider moisture-proof packaging to prevent moisture absorption.
また、 上述の錠剤温度は市販の各種機器を用いて測定可能であり、 例えば非接 触温度計等を用いて測定可能である。 非接触温度計による測定誤差は、 一般に読 取値の ± 1 % (又は ± 2 ) 程度である。  The above-mentioned tablet temperature can be measured using various commercially available devices, for example, using a non-contact thermometer or the like. The measurement error with a non-contact thermometer is generally about ± 1% (or ± 2) of the reading.
本発明を以下の実施例及び試験例により更に詳細に説明する。 尚、 錠剤温度は ポータブル型非接触温度計 PT— 3 LF (ォプテックス株式会社製) を用いて測 定した。 The present invention will be described in more detail by the following examples and test examples. The tablet temperature is The measurement was performed using a portable non-contact thermometer PT-3 LF (made by Optex Corporation).
[実施例 1 ]  [Example 1]
ポリアリルアミン エピクロルヒドリン架橋重合体(一般名:塩酸セべラマー( r 一 I NN) 、 水分含有量 5. 5重量%) 86. 2 1重量%、 結晶セルロース 1 3. 62重量%、 ラブリワックス 1 01 0. 12重量%を 型混合機に投入し、 1 5 r pmで 1 5分間混合したのち、 これにステアリン酸マグネシウム 0. 05重 量%を投入し、 更に 1 5 r pmで 1分間混合した。 この混合末を口一タリー式打 錠機(畑鐡ェ所製 X— 45型)にて打錠して素錠 (水分含有量 5. 5重量%、 硬度 10 k g f ) を製造した。 水分含有量は乾燥減量法 (105で、 3時間) により 測定した。 Polyallylamine epichlorohydrin cross-linked polymer (generic name: sevelamer hydrochloride (r-INN), water content 5.5% by weight) 86.2 1% by weight, crystalline cellulose 1 3.62% by weight, Lubriwax 101 0.12% by weight was put into a mold mixer, mixed at 15 rpm for 15 minutes, then 0.05% by weight of magnesium stearate was added thereto, and further mixed at 15 rpm for 1 minute. . This mixed powder was tableted with a single-tally tableting machine (X-45 manufactured by Hattetsu Corporation) to produce uncoated tablets (water content: 5.5% by weight, hardness: 10 kgf). The water content was measured by the loss on drying method (105, 3 hours).
[実施例 2 ]  [Example 2]
実施例 1で得られた素錠をシリカゲル入りデシケ一夕中で乾燥し、 水分含有量 が 3. 0重量%の素錠及び水分含有量が 3. 8重量%の素錠を調製した。 水分含 有量は乾燥減量法 (105°C、 3時間) により測定した。  The uncoated tablet obtained in Example 1 was dried overnight in a desiccator containing silica gel to prepare an uncoated tablet having a water content of 3.0% by weight and an uncoated tablet having a water content of 3.8% by weight. The water content was measured by the drying loss method (105 ° C, 3 hours).
[実施例 3]  [Example 3]
実施例 1で得られた素錠を、 室内で吸湿させ、 水分含有量が 8. 0重量%の素 錠を調製した。 水分含有量は乾燥減量法 (105で、 3時間) により測定した。  The uncoated tablet obtained in Example 1 was absorbed in a room to prepare an uncoated tablet having a water content of 8.0% by weight. The water content was measured by the loss on drying method (105 hours, 3 hours).
[試験例 1 ]  [Test Example 1]
実施例 1で得られた素錠を 40 、 501:、 60°C、 70での恒温漕に入れ、 5分おきに 60分までサンプリングを行い、 厚み計によって錠剤の厚みを計測し た。 各温度における錠剤の厚み増加量 (加温前との差) の時間推移を表す結果の 一例を図 1に示す。  The uncoated tablets obtained in Example 1 were placed in a constant temperature bath at 40, 501 :, 60 ° C. and 70, sampling was performed every 5 minutes up to 60 minutes, and the thickness of the tablets was measured with a thickness gauge. Fig. 1 shows an example of the results showing the time course of the tablet thickness increase (difference from before heating) at each temperature.
[試験例 2]  [Test Example 2]
実施例 1で得られた素錠 (水分含有量 5. 5重量%) 、 実施例 2で得られた素 錠 (水分含有量 3. 0重量%及び水分含有量 3. 8重量%) 及び実施例 3で得ら れた素錠 (水分含有量 8. 0重量%) を、 それぞれ 60 、 70で、 80" の恒 温漕に入れ、 10分おきに 30分までサンプリングを行い、 厚み計によって錠剤 厚みを計測した。 各温度における錠剤の厚み増加量の時間推移を表す結果の一例 を、 それぞれ図 2〜図 5に示す。 The uncoated tablet obtained in Example 1 (water content 5.5% by weight), the uncoated tablet obtained in Example 2 (water content 3.0% by weight and water content 3.8% by weight) and The uncoated tablets (water content 8.0% by weight) obtained in Example 3 were placed in an 80 "constant temperature bath at 60 and 70, respectively, and sampled every 10 minutes until 30 minutes. Example of the results showing the time change of the tablet thickness increase at each temperature Are shown in FIGS. 2 to 5, respectively.
[実施例 4]  [Example 4]
ヒドロキシプロピルメチルセルロース 6. 5重量%、マクロゴール 600 0 1 重量%、 酸化チタン 2重量%及びタルク 0. 5重量%を精製水 90重量% に溶解或いは分散させコーティング液を調製した。  6.5% by weight of hydroxypropyl methylcellulose, 600% by weight of macrogol, 2% by weight of titanium oxide and 0.5% by weight of talc were dissolved or dispersed in 90% by weight of purified water to prepare a coating solution.
次に、 実施例 1で調製した素錠 5. 0 k gをコーティング機 (パゥレック製、 0 (:— 500型) に投入した。 給気設定温度 55 で 1 0分間予備乾燥した。 予備乾燥終了時の錠剤温度は 5 1でであった。 次に、 給気設定温度 5 3°Cにて、 スプレー液の噴霧量を 60分後まで 6mgZ分で、 それ以降 1 2mgZ分で噴霧 し、 2 1 0分間スプレーを行った。 この間の錠剤温度は 45〜49 であった。 スプレー終了後に、 給気設定温度を 7 0でとし、 後乾燥を 1 8 0分間行った。 後 乾燥終了後の錠剤温度は 7 3°Cであった。  Next, 5.0 kg of the uncoated tablets prepared in Example 1 were put into a coating machine (PAREX, 0 (: -500 type)) and preliminarily dried for 10 minutes at a set air supply temperature of 55. The tablet temperature was 51. Then, at the set air supply temperature of 53 ° C, the spray amount of the spray liquid was sprayed at 6 mgZ minutes until 60 minutes later, and then sprayed at 12 mgZ minutes, and 2 1 Spraying was performed for 0 minutes, and the tablet temperature during this period was 45 to 49. After spraying, the air supply set temperature was set to 70, and post-drying was performed for 180 minutes. Was 73 ° C.
[実施例 5]  [Example 5]
実施例 1で製造した素錠と、 実施例 4で調製したコーティング液を用いて行つ た。 実施例 1で調製した素錠 1 9 5. 8 k gをコーティング機 (フロイント産業 製、 HCF— 1 50型) に投入した。 給気設定温度 7 0でで 9分間予備乾燥した。 予備乾燥終了時の錠剤温度は 5 2でであった。 次に、 給気設定温度 58〜8 0 にて、 スプレー液の噴霧量を 6 0分後まで 24 OmLZ分で、 それ以降 1 2 0分 後まで 30 OmL/分で、 それ以降 36 OmLZ分で噴霧し、 2 22分間スプレ 一を行った。 この間の錠剤温度は 48〜 54 であった。 スプレー終了後に、 給 気設定温度を 70でとし、 後乾燥を 3 60分間行った。 後乾燥終了時の錠剤温度 は 7 5 であった。  The test was carried out using the uncoated tablet produced in Example 1 and the coating solution prepared in Example 4. 195.8 kg of the uncoated tablet prepared in Example 1 was put into a coating machine (HCF-150, manufactured by Freund Corporation). Preliminary drying was performed at a set air supply temperature of 70 for 9 minutes. The tablet temperature at the end of predrying was 52. Next, at the set air supply temperature of 58 to 80, the spraying amount of the spray liquid was 24 OmLZ minutes until 60 minutes later, 30 OmL / minute until 120 minutes later, and 36 OmLZ minutes thereafter. Sprayed and sprayed for 222 minutes. The tablet temperature during this period was 48-54. After the end of spraying, the air supply set temperature was set to 70, and post-drying was performed for 360 minutes. The tablet temperature at the end of post-drying was 75.
[実施例 6 ]  [Example 6]
実施例 1と同等の素錠と、実施例 4で調製したコーティング液を用いて行った。 実施例 1に従って調製した素錠 2 0 7. 4 k gをコーティング機 (フロイント産 業製、 AQC— 1 50 F型) に投入した。 給気設定温度 50〜7 5 で 1 8分間 予備乾燥した。 予備乾燥終了時の錠剤温度は 42t:であった。 次に、 給気設定温 度 5 7〜7 5でにて、 スプレー液の噴霧量を 6 0分後まで 3 2 OmLZ分で、 そ れ以降 1 2 0分後まで 40 OmL/分で、 それ以降 48 OmL/分で噴霧し、 1 8 0分間スプレーを行った。 この間の錠剤温度は 4 2〜4 8でであった。 スプレ 一終了後に、 給気設定温度を 7 0でとし、 後乾燥を 1 2 0分間行った。 後乾燥終 了時の錠剤温度は 6 8でであった。 The test was performed using the same uncoated tablet as in Example 1 and the coating liquid prepared in Example 4. 200,4 kg of uncoated tablets prepared according to Example 1 were charged into a coating machine (AQC-150F, manufactured by Freund Corporation). It was pre-dried for 18 minutes at a set air supply temperature of 50-75. The tablet temperature at the end of the preliminary drying was 42 t :. Next, at the set air supply temperature of 57 to 75, the spray amount of the spray liquid was 32 OmLZ minutes until 60 minutes later, and 40 OmL / minute until 120 minutes thereafter. Spray at 48 OmL / min. Sprayed for 80 minutes. The tablet temperature during this time was 42-48. After the spraying, the set air supply temperature was set at 70, and post-drying was performed for 120 minutes. The tablet temperature at the end of post-drying was 68.
[比較例 1 ]  [Comparative Example 1]
実施例 1で製造した素錠と、 実施例 4で調製したコーティング液を用いて行つ た。 実施例 1で調製した素錠 5 . 0 k gをコーティング機 (パゥレック製、 D R C— 5 0 0型) に投入した。 給気設定温度 7 0でで 1 0 5分間予備乾燥した。 予 備乾燥終了時の錠剤温度は 7 2 であった。 次に、 給気設定温度 5 5〜6 0でに て、 スプレー液の噴霧量を 3 0分後まで 6 m g Z分で、 それ以降 1 2 m g Z分で 噴霧し、 1 7 0分間スプレーを行った。 この間の錠剤温度は 4 4〜6 5でであつ た。 スプレー終了後に、 給気設定温度を 7 0でとし、 後乾燥を 6 0分間行った。 後乾燥終了後の錠剤温度は 6 8 であった。  The test was carried out using the uncoated tablet produced in Example 1 and the coating solution prepared in Example 4. 5.0 kg of the uncoated tablet prepared in Example 1 was charged into a coating machine (PARC, DRC-500 type). Preliminary drying was performed at an air supply set temperature of 70 for 105 minutes. The tablet temperature at the end of predrying was 72. Next, at the set air supply temperature of 55 to 60, spray the spray liquid at 6 mg Z minutes until 30 minutes later, spray at 12 mg Z minutes thereafter, and spray for 170 minutes. went. The tablet temperature during this period was 44-65. After the spraying, the air supply set temperature was set at 70 and post-drying was performed for 60 minutes. The tablet temperature after the post-drying was 68.
[試験例 3 ]  [Test Example 3]
実施例 4、 5及び比較例 1で製造したコーティング錠剤の表面の平滑度を目視 観察により比較した。 結果を表 1に示す。 また、 各錠剤の写真の一例を図 6〜図 1 0に示す。  The surface smoothness of the coated tablets manufactured in Examples 4 and 5 and Comparative Example 1 was compared by visual observation. Table 1 shows the results. Examples of photographs of each tablet are shown in FIGS.
また、 目視観察により良好と判定された錠剤と不良と判定された錠剤では、 R a (算術平均粗さ) に有意な差異が確認された。 尚、 R a (算術平均粗さ) は、 走査型レーザー顕微鏡を用いた画像解析や、 表面粗さ測定機のような市販の機器 により測定することができる。  In addition, a significant difference in Ra (arithmetic mean roughness) was confirmed between the tablets determined to be good and those determined to be poor by visual observation. In addition, Ra (arithmetic mean roughness) can be measured by image analysis using a scanning laser microscope or a commercially available device such as a surface roughness measuring device.
[表 1 ]  [table 1 ]
Figure imgf000021_0001
Figure imgf000021_0001
[産業上の利用可能性] [Industrial applicability]
上記の試験例から明らかなように、 本発明の製造方法は従来技術の問題点を解 決し、 従来提供することができなかった錠剤表面の平滑度が優れ、 均一にコーテ ィングされた、 吸湿性高分子を主成分とするコーティング錠剤を提供することが 可能である。 As is clear from the above test examples, the production method of the present invention solves the problems of the prior art, has excellent tablet surface smoothness that could not be provided conventionally, has a uniform coating, and has a hygroscopic property. Providing coated tablets based on polymers It is possible.
また本発明の如く、 吸湿性高分子を 5 0 %以上含有する素錠を熱膨張能が完全 に失われない条件(即ち、素錠の熱膨脹能が少なくとも一部残されるような条件) で予備加熱し、 次いでコーティング液を塗布しながら又は塗布した後、 加熱錠剤 を熱膨張させることにより、 コーティングの初期に発生した錠剤の表面の荒れを 修復するという製造方法は、 新規且つユニークなものであり、 錠剤製造にあたつ て新たな見地を開く、 非常に有益且つ有用なものである。  Further, as in the present invention, the uncoated tablet containing 50% or more of the hygroscopic polymer is preliminarily subjected to the condition that the thermal expansion ability is not completely lost (that is, the condition that at least a part of the uncoated tablet has the thermal expansion ability). A new and unique manufacturing method that repairs the rough surface of the tablet that occurred at the beginning of coating by heating and then thermally expanding the heated tablet with or after applying the coating liquid. It is a very useful and useful tool that opens a new perspective in tablet manufacturing.

Claims

請 求 の 範 囲 The scope of the claims
1 . 吸湿性高分子を 5 0重量%以上含有する素錠を、 その熱膨張能が完全には 失われない条件で予備加熱し、 次いでコーティング液を塗布しながら又は塗布し た後、 錠剤を十分に膨張させるような条件下に保持することにより該錠剤の表面 形状の修復を行うことを特徴とする、 吸湿性高分子を主成分とするコーティング 錠剤の製造方法。 1. Pre-heat a plain tablet containing 50% by weight or more of a hygroscopic polymer under the condition that its thermal expansion capacity is not completely lost, and then apply the coating solution or after applying the coating solution. A method for producing a coated tablet containing a hygroscopic polymer as a main component, wherein the surface shape of the tablet is restored by maintaining the tablet under conditions that allow it to expand sufficiently.
2 . コーティング錠剤がフィルムコーティング錠剤である請求項 1記載の製造 方法。  2. The method according to claim 1, wherein the coated tablet is a film-coated tablet.
3 . 素錠の水分含有量が 1 0重量%以下である請求項 1又は 2記載の製造方法。  3. The method according to claim 1, wherein the uncoated tablet has a water content of 10% by weight or less.
4 . 素錠に含まれる吸湿性高分子が 7 0重量%以上である請求項 1乃至 3の何 れか一項に記載の製造方法。 4. The production method according to any one of claims 1 to 3, wherein the unabsorbed tablet contains 70% by weight or more of the hygroscopic polymer.
5 . 吸湿性高分子がポリアリルアミン系高分子である請求項 1乃至 4の何れか 一項に記載の製造方法。  5. The method according to claim 1, wherein the hygroscopic polymer is a polyallylamine-based polymer.
6 . 吸湿性高分子がポリアリルアミンをェピクロルヒドリンにより架橋重合し た高分子である請求項 1乃至 5の何れか一項に記載の製造方法。  6. The production method according to any one of claims 1 to 5, wherein the hygroscopic polymer is a polymer obtained by crosslinking and polymerizing polyallylamine with epichlorohydrin.
7 . 請求項 1乃至 6の何れか一項に記載の製造方法により得られるコ一ティン グ錠剤。 7. Coating tablets obtained by the production method according to any one of claims 1 to 6.
PCT/JP2002/013297 2001-12-20 2002-12-19 Coated tablets and process for producing the same WO2003053419A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002357611A AU2002357611A1 (en) 2001-12-20 2002-12-19 Coated tablets and process for producing the same
KR10-2004-7009561A KR20040073492A (en) 2001-12-20 2002-12-19 Coated tablets and process for producing the same
JP2003554178A JP4398253B2 (en) 2001-12-20 2002-12-19 Coated tablet and method for producing the same
HK05104710A HK1071524A1 (en) 2001-12-20 2005-06-06 Coated tablets and process for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-387508 2001-12-20
JP2001387508 2001-12-20

Publications (1)

Publication Number Publication Date
WO2003053419A1 true WO2003053419A1 (en) 2003-07-03

Family

ID=19188073

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/013297 WO2003053419A1 (en) 2001-12-20 2002-12-19 Coated tablets and process for producing the same

Country Status (7)

Country Link
JP (1) JP4398253B2 (en)
KR (1) KR20040073492A (en)
CN (1) CN1298315C (en)
AU (1) AU2002357611A1 (en)
HK (1) HK1071524A1 (en)
TW (1) TWI231760B (en)
WO (1) WO2003053419A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008517022A (en) * 2004-10-19 2008-05-22 クルカ, トバルナ ズドラビル, デー.デー., ノボ メスト Solid pharmaceutical composition containing donepezil hydrochloride

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200484651Y1 (en) 2015-11-10 2017-10-12 윤범수 Hair roll brush
CN107929254A (en) * 2017-11-30 2018-04-20 南京恒生制药有限公司 A kind of coating method of 2-Propen-1-amine polymer with(chloromethyl)oxirane carbonate piece

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448231A1 (en) * 1990-02-22 1991-09-25 McNEIL-PPC, INC. Improved coated medicaments and apparatus and methods for making same
WO1998044933A1 (en) * 1997-04-04 1998-10-15 Chugai Seiyaku Kabushiki Kaisha Phosphate-binding polymer preparations
WO2000003696A1 (en) * 1998-07-17 2000-01-27 Bristol-Myers Squibb Company Enteric coated pharmaceutical tablet and method of manufacturing
WO2000012064A1 (en) * 1998-08-28 2000-03-09 Andrx Pharmaceuticals, Inc. Omeprazole formulation
WO2000022008A1 (en) * 1998-10-12 2000-04-20 Chugai Seiyaku Kabushiki Kaisha Polymer combining with phosphoric acid and preparation containing the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448231A1 (en) * 1990-02-22 1991-09-25 McNEIL-PPC, INC. Improved coated medicaments and apparatus and methods for making same
WO1998044933A1 (en) * 1997-04-04 1998-10-15 Chugai Seiyaku Kabushiki Kaisha Phosphate-binding polymer preparations
WO2000003696A1 (en) * 1998-07-17 2000-01-27 Bristol-Myers Squibb Company Enteric coated pharmaceutical tablet and method of manufacturing
WO2000012064A1 (en) * 1998-08-28 2000-03-09 Andrx Pharmaceuticals, Inc. Omeprazole formulation
WO2000022008A1 (en) * 1998-10-12 2000-04-20 Chugai Seiyaku Kabushiki Kaisha Polymer combining with phosphoric acid and preparation containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008517022A (en) * 2004-10-19 2008-05-22 クルカ, トバルナ ズドラビル, デー.デー., ノボ メスト Solid pharmaceutical composition containing donepezil hydrochloride

Also Published As

Publication number Publication date
AU2002357611A1 (en) 2003-07-09
TW200301140A (en) 2003-07-01
CN1604771A (en) 2005-04-06
KR20040073492A (en) 2004-08-19
HK1071524A1 (en) 2005-07-22
CN1298315C (en) 2007-02-07
JPWO2003053419A1 (en) 2005-04-28
TWI231760B (en) 2005-05-01
JP4398253B2 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
AU2003211146B2 (en) Controlled release dosage forms
US5830503A (en) Enteric coated diltiazem once-a-day formulation
US20060159755A1 (en) Method for producing a controlled release preparation
CA2488860A1 (en) Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
EP0776660A2 (en) Long-lasting release nifedipine preparation
JP6402191B2 (en) Film-coated tablet containing choline alphosserate and method for producing the same
Cao et al. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions
BRPI0922670B1 (en) COATING MATERIAL FOR SOLID PHARMACEUTICAL FORMULATION, AND SOLID PHARMACEUTICAL FORMULATION
JP2008507482A (en) Multi-layer dosage form
CN107405311B (en) Apremilast sustained release preparation
CA2869525A1 (en) New formulation
CA2982425A1 (en) Ribociclib tablet
JP2782691B2 (en) Stabilization of enteric-coated preparations
CN103784414A (en) Esomeprazole enteric-coated tablets and preparation method thereof
WO2003053419A1 (en) Coated tablets and process for producing the same
KR20160043611A (en) An extended release pharmaceutical formulation of metformin and a preparation method thereof
AU2012227936A1 (en) Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
EP1909761A1 (en) Pharmaceutical composition comprising granular pantoprazole
JP2001163774A (en) Solid preparation including bromhexine hydrochloride
WO2003096874A2 (en) Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
JP2007504195A (en) Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer
WO2008065107A1 (en) Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film
US20030236285A1 (en) Stabilized pharmaceutical compositions containing benzimidazole compounds
JP2007091620A (en) Film-coated tablet
US20160015646A1 (en) Oral delivery system for sorafenib tosylate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003554178

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 20028253760

Country of ref document: CN

Ref document number: 1020047009561

Country of ref document: KR

122 Ep: pct application non-entry in european phase